[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,946,1014,1291,1365,1459,1546,1616,1687],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":25,"verifyTime":776,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":786,"fullTextUrl":26,"authors":787,"publicationType":747,"publisherRelationship":930,"citationCount":26,"citationInfo":26,"publishDate":944,"publishYear":945,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"b9d919ba-5a3f-4154-a96d-14aefb3fe59e","2024-01-12T05:14:08.040+00:00","2025-02-07T08:47:32.850+00:00",[],"Linfadenectom%C3%ADas-en-el-c%C3%A1ncer-de-endometrio",{"references":780,"title":782,"doi":784},{"VOID":781},"Morrow, 1991, Relationship between surgical-pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: a gynecologic oncology group study, Gynecol Oncol, 40, 55, 10.1016\u002F0090-8258(91)90086-K\nBrémond, 2001, Standards, options, recommandations pour la prise en charge des patientes atteintes d’un cancer de l’endomètre, Bull Cancer, 88, 181\nKamina, 1979\nMariani, 2008, Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging, Gynecol Oncol, 109, 11, 10.1016\u002Fj.ygyno.2008.01.023\nLécuru, 1997, Lymphatic drainage of the uterus. Preliminary results of an experimental study, J Gynecol Obstet Biol Reprod, 26, 418\nBurke, 1996, Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study, Gynecol Oncol, 62, 169, 10.1006\u002Fgyno.1996.0211\nBallester, 2011, Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO), Lancet Oncol, 12, 469, 10.1016\u002FS1470-2045(11)70070-5\nCreasman, 1987, Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study, Cancer, 60, 2035, 10.1002\u002F1097-0142(19901015)60:8+\u003C2035::AID-CNCR2820601515>3.0.CO;2-8\nChi, 2008, The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology, Int J Gynecol Cancer, 18, 269, 10.1111\u002Fj.1525-1438.2007.00996.x\nBaekelandt, 2009, Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up, Ann Oncol, 20, iv29, 10.1093\u002Fannonc\u002Fmdp120\nAbu-Rustum, 2008, Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?, Am J Obstet Gynecol, 198, 457, 10.1016\u002Fj.ajog.2008.01.010\nLutman, 2006, Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology, Gynecol Oncol, 102, 92, 10.1016\u002Fj.ygyno.2005.11.032\nPomel, 2012, Systematic (complete) para-aortic lymphadenectomy: description of a novel surgical classification with technical and anatomical considerations, BJOG, 119, 249, 10.1111\u002Fj.1471-0528.2011.03171.x\nRoland, 2004, The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment, Gynecol Oncol, 93, 125, 10.1016\u002Fj.ygyno.2003.12.018\nMacdonald, 2005, Does oncologic specialization influence outcomes following surgery in early stage adenocarcinoma of the endometrium?, Gynecol Oncol, 99, 730, 10.1016\u002Fj.ygyno.2005.07.111\nLécuru F, Bats AS, Bensaid C, Achouri A, Nos C, Faraggi M, et al. Technique et résultats du prélèvement du ganglion sentinelle dans les cancers du col et du corps de l’utérus. EMC (Elsevier Masson SAS, Paris), Techniques chirurgicales – Gynécologie, 41-710, 2012.\nAbu-Rustum, 2009, Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?, Gynecol Oncol, 113, 163, 10.1016\u002Fj.ygyno.2009.01.003\nRaspagliesi, 2004, Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study, Am J Obstet Gynecol, 191, 435, 10.1016\u002Fj.ajog.2004.03.008\nAltgassen, 2007, A new approach to label sentinel nodes in endometrial cancer, Gynecol Oncol, 105, 457, 10.1016\u002Fj.ygyno.2007.01.021\nCragun, 2005, Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer, J Clin Oncol, 23, 3668, 10.1200\u002FJCO.2005.04.144\nTodo, 2010, Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis, Lancet, 375, 1165, 10.1016\u002FS0140-6736(09)62002-X\nBenedetti Panici, 2008, Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial, J Natl Cancer Inst, 100, 1707, 10.1093\u002Fjnci\u002Fdjn397\nASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125–36.\nCreasman, 2010, ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid?, Gynecol Oncol, 116, 293, 10.1016\u002Fj.ygyno.2009.10.065\nAbu-Rustum, 2006, The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center, Gynecol Oncol, 103, 714, 10.1016\u002Fj.ygyno.2006.03.055\nAchouri, 2013, Complications of lymphadenectomy for gynecologic cancer, Eur J Surg Oncol, 39, 81, 10.1016\u002Fj.ejso.2012.10.011\nAalders, 2007, Endometrial cancer – revisiting the importance of pelvic and para aortic lymph nodes, Gynecol Oncol, 104, 222, 10.1016\u002Fj.ygyno.2006.10.013\nCorn, 1994, Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of the surgically staged endometrial cancer patients: a multivariate analysis, J Clin Oncol, 12, 510, 10.1200\u002FJCO.1994.12.3.510\nINCa. Cancer de l’endomètre. Recommandations professionnelles. Accès : www.e-cancer.fr.\nSavelli, 2012, A prospective blinded comparison of the accuracy of transvaginal sonography and frozen section in the assessment of myometrial invasion in endometrial cancer, Gynecol Oncol, 124, 549, 10.1016\u002Fj.ygyno.2011.11.016",{"ES":783},"Linfadenectomías en el cáncer de endometrio",{"VOID":785},"10.1016\u002Fs1283-081x(15)74742-9","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X15747429",[788,813,832,861,880,906,918],{"id":789,"sortIndex":114,"researcher":26,"roles":790,"affiliations":791,"properties":810},"b707773f-8cb8-4c8a-b832-0e1c667900ab",[696],[792,802],{"id":793,"sortIndex":115,"affiliation":794,"properties":801},"2c03aeec-b5df-47ba-a795-21aca06ec26b",{"id":795,"createTime":796,"updateTime":796,"relativeEntities":797,"slug":26,"properties":798,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"68fe197a-8336-4ac0-8f76-054ccb6a9560","2023-12-17T18:40:32.628+00:00",[],{"title":799},{"VI":800},"Faculté de médecine, université Paris-Descartes, 12, rue de l’École-de-Médecine, 75006 Paris, France",{},{"id":26,"sortIndex":36,"affiliation":803,"properties":26},{"id":804,"createTime":805,"updateTime":805,"relativeEntities":806,"slug":26,"properties":807,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"bb15d7c9-0c48-4bc2-b550-2319d69d2f70","2024-01-12T05:14:08.053+00:00",[],{"title":808},{"VI":809},"Service de chirurgie cancérologique gynécologique et du sein, Hôpital européen Georges-Pompidou, Assistance publique–Hôpitaux de Paris, 20, rue Leblanc, 75015 Paris, France",{"title":811},{"VI":812},"C. Ngô",{"id":814,"sortIndex":162,"researcher":26,"roles":815,"affiliations":816,"properties":829},"992eab9c-edfa-4011-b7cf-df30697c422d",[696],[817,824],{"id":818,"sortIndex":115,"affiliation":819,"properties":823},"69bcfc3e-bd3e-4602-9cf7-146aeeb253cf",{"id":795,"createTime":796,"updateTime":796,"relativeEntities":820,"slug":26,"properties":821,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":822},{"VI":800},{},{"id":26,"sortIndex":36,"affiliation":825,"properties":26},{"id":804,"createTime":805,"updateTime":805,"relativeEntities":826,"slug":26,"properties":827,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":828},{"VI":809},{"title":830},{"VI":831},"L. Makke",{"id":833,"sortIndex":115,"researcher":26,"roles":834,"affiliations":835,"properties":858},"c48355c3-c20d-486f-9e63-724690581974",[696],[836,843,848],{"id":837,"sortIndex":115,"affiliation":838,"properties":842},"41a5e9a5-bcbf-4b7c-89c7-00de2bbe2dc9",{"id":795,"createTime":796,"updateTime":796,"relativeEntities":839,"slug":26,"properties":840,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":841},{"VI":800},{},{"id":26,"sortIndex":36,"affiliation":844,"properties":26},{"id":804,"createTime":805,"updateTime":805,"relativeEntities":845,"slug":26,"properties":846,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":847},{"VI":809},{"id":849,"sortIndex":114,"affiliation":850,"properties":857},"554850d3-830b-4cf3-a892-34df2b52f4cb",{"id":851,"createTime":852,"updateTime":852,"relativeEntities":853,"slug":26,"properties":854,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1856649b-6613-4d0c-840f-23308c9cebdf","2024-01-12T05:14:08.075+00:00",[],{"title":855},{"VI":856},"Inserm UMR S 747, Université Paris-Descartes, Centre universitaire des Saints-Pères, 45, rue des Saints-Pères, 75270 Paris cedex 06, France",{},{"title":859},{"VI":860},"A.-S. Bats",{"id":862,"sortIndex":111,"researcher":26,"roles":863,"affiliations":864,"properties":877},"db6586c5-b752-49e0-b5cb-b7e20174cd00",[696],[865,872],{"id":866,"sortIndex":115,"affiliation":867,"properties":871},"b16c609e-5ac0-4c5f-8c04-d46b5aaaf1c6",{"id":795,"createTime":796,"updateTime":796,"relativeEntities":868,"slug":26,"properties":869,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":870},{"VI":800},{},{"id":26,"sortIndex":36,"affiliation":873,"properties":26},{"id":804,"createTime":805,"updateTime":805,"relativeEntities":874,"slug":26,"properties":875,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":876},{"VI":809},{"title":878},{"VI":879},"A. Achouri",{"id":881,"sortIndex":36,"researcher":26,"roles":882,"affiliations":883,"properties":903},"7e36136b-0312-465e-a3e6-8aba9839035e",[696],[884,891,898],{"id":885,"sortIndex":114,"affiliation":886,"properties":890},"20ac0bff-c72f-4172-a103-942eb6907377",{"id":851,"createTime":852,"updateTime":852,"relativeEntities":887,"slug":26,"properties":888,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":889},{"VI":856},{},{"id":892,"sortIndex":115,"affiliation":893,"properties":897},"1030d9c4-c04c-4e3e-acb6-d703c342670c",{"id":795,"createTime":796,"updateTime":796,"relativeEntities":894,"slug":26,"properties":895,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":896},{"VI":800},{},{"id":26,"sortIndex":36,"affiliation":899,"properties":26},{"id":804,"createTime":805,"updateTime":805,"relativeEntities":900,"slug":26,"properties":901,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":902},{"VI":809},{"title":904},{"VI":905},"F. Lécuru",{"id":907,"sortIndex":135,"researcher":26,"roles":908,"affiliations":909,"properties":915},"663ca9e4-ade3-4613-9de7-c5d7764975e9",[696],[910],{"id":26,"sortIndex":36,"affiliation":911,"properties":26},{"id":804,"createTime":805,"updateTime":805,"relativeEntities":912,"slug":26,"properties":913,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":914},{"VI":809},{"title":916},{"VI":917},"C. Nos",{"id":919,"sortIndex":59,"researcher":26,"roles":920,"affiliations":921,"properties":927},"df92dca5-db1a-4dcb-aa75-9c0527919477",[696],[922],{"id":26,"sortIndex":36,"affiliation":923,"properties":26},{"id":804,"createTime":805,"updateTime":805,"relativeEntities":924,"slug":26,"properties":925,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":926},{"VI":809},{"title":928},{"VI":929},"C. Bensaid",{"url":786,"publisher":931,"properties":939},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":932,"slug":662,"properties":933,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":936,"manageAffiliations":937,"indexDatabases":938,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":934,"title":935},{"VOID":665},{"EN":667},[],[],[],{"volume":940,"pages":942},{"VOID":941},"51",{"VOID":943},"1-6","2015-12-01",2015,{"id":947,"createTime":948,"updateTime":948,"relativeEntities":949,"slug":26,"properties":950,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":957,"fullTextUrl":26,"authors":958,"publicationType":747,"publisherRelationship":998,"citationCount":26,"citationInfo":26,"publishDate":1012,"publishYear":1013,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e4ac5b66-eae3-4d43-bc88-c34a1ef5d73a","2023-12-12T03:53:07.952+00:00",[],{"references":951,"title":953,"doi":955},{"VOID":952},"Ibanez, 2000, Premature adrenarche: normal variant or forerunner of adult disease?, Endocr. Rev., 21, 671, 10.1210\u002Fer.21.6.671\nApter, 1993, Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins, J. Clin. Endocrinol. Metab., 76, 940, 10.1210\u002Fjc.76.4.940\nIbanez, 1998, Possible genesis of polycystic ovary syndrom in the periadolescent girl, Curr. Opin. Endocrinol Diab, 5, 19, 10.1097\u002F00060793-199802000-00004\nvan Hooff, 2004, Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years, Hum. Reprod., 19, 383, 10.1093\u002Fhumrep\u002Fdeh079\nLobo, 1991, Ovarian hyperandrogenism and androgen producing tumors, Endocrinol. Metab. Clin. North Am., 20, 773, 10.1016\u002FS0889-8529(18)30244-5\nYoung, 1985, Ovarian Sertoli-Leydig cell tumors: a clinicopathological analysis of 207 cases, Am. J. Surg. Pathol., 9, 543, 10.1097\u002F00000478-198508000-00001\nCaron, 1993, Androgenic granulosa cell tumor of the ovary: in vivo hormonal studies, J. Endocrinol. Invest., 16, 545, 10.1007\u002FBF03348903\nAbbott, 2002, Developmental origin of polycystic ovary syndrome-a hypothesis, J. Endocrinol., 174, 1, 10.1677\u002Fjoe.0.1740001\nStrauss, 1999, Molecular mysteries of polycystic ovary syndrome, Mol. Endocrinol., 13, 800, 10.1210\u002Fme.13.6.800\nDunaif, 1997, Insulin resistance and the polycystic ovarian syndrome: mechanism and implications for pathogenesis, Endocr. Rev., 18, 774, 10.1210\u002Fer.18.6.774\nWebber, 2003, Formation and early development of follicles in the polycystic ovary, Lancet, 362, 1017, 10.1016\u002FS0140-6736(03)14410-8\nDewailly, 1997, Definition, clinical manifestations, and prevalance of PCOS, 259\nZacur, 1997, Prolactin abnormalities in PCOS, 287\n2004, The Rotterdam ESHRE\u002FASRM sponsored PCOS consensus workshop group, Hum. Reprod., 19, 41\nBalen, 2003, Ultrasound assessment of the polycystic ovary: international consensus definitions, Hum. Reprod. Update, 9, 505, 10.1093\u002Fhumupd\u002Fdmg044\nForest, 1992, Formes non classiques dites « tardives » du déficit en 21-hydroxylase : diagnostic différentiel avec les hétérozygotes et conseil génétique, Rev. Fr. Endocrinol. Clin., 33, 47\nDewailly, 1997, Pathophysiology and clinical manifestations of nonclassic 21-hydroxylase deficiency, 173\nAzziz, 1997, Idiopathic Hirsutism: definition, prevalence and inheritance, 529\nCortet-Rudelli, 1997, Drug-induced androgen excess, 613\nNelson-DeGrave, 2004, Valproate potentiates androgen biosynthesis in human ovarien theca cells, Endocrinology, 145, 799, 10.1210\u002Fen.2003-0940\nDiamanti-Kandarakis, 1997, Cushing's disease and androgen excess, 569\nDeroubaix-Allard, 1997, Acromegaly and androgen excess, 585\nAzziz, 1997, Diagnosis, screening, and treatment of nonclassic 21-hydroxylase deficiency, 181\nSpritzer, 1990, Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia, J. Clin. Endocrinol. Metab., 70, 642, 10.1210\u002Fjcem-70-3-642\nIbanez, 2004, Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide, J. Clin. Endocrinol. Metab., 89, 4716, 10.1210\u002Fjc.2004-0047\nKorytkowski, 1995, Metabolic effects of oral contraceptives in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 80, 3327, 10.1210\u002Fjc.80.11.3327",{"ES":954},"Hiperandrogenismo en la adolescente",{"VOID":956},"10.1016\u002Fs1283-081x(06)46492-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06464924",[959,974,986],{"id":960,"sortIndex":114,"researcher":26,"roles":961,"affiliations":962,"properties":971},"6cfd7a71-c611-4f3f-bcf0-f2ea5b695550",[696],[963],{"id":26,"sortIndex":36,"affiliation":964,"properties":26},{"id":965,"createTime":966,"updateTime":966,"relativeEntities":967,"slug":26,"properties":968,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"38c841f4-3384-42fa-b581-8e6f69a378a8","2023-12-12T03:53:07.978+00:00",[],{"title":969},{"VI":970},"Service de gynécologie endocrinienne et de médecine de la reproduction, centre hospitalier universitaire de Lille, hôpital Jeanne de Flandre, 2, avenue Oscar-Lambert, 59037 Lille cedex, France",{"title":972},{"VI":973},"D. Dewailly",{"id":975,"sortIndex":115,"researcher":26,"roles":976,"affiliations":977,"properties":983},"5c0b4907-873d-4c44-a4b3-b27503c92a1e",[696],[978],{"id":26,"sortIndex":36,"affiliation":979,"properties":26},{"id":965,"createTime":966,"updateTime":966,"relativeEntities":980,"slug":26,"properties":981,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":982},{"VI":970},{"title":984},{"VI":985},"S. Jonard",{"id":987,"sortIndex":36,"researcher":26,"roles":988,"affiliations":989,"properties":995},"200596ea-d35a-46a9-a3c0-ff3aea2f23d5",[696],[990],{"id":26,"sortIndex":36,"affiliation":991,"properties":26},{"id":965,"createTime":966,"updateTime":966,"relativeEntities":992,"slug":26,"properties":993,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":994},{"VI":970},{"title":996},{"VI":997},"C. Richard",{"url":957,"publisher":999,"properties":1007},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1000,"slug":662,"properties":1001,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1004,"manageAffiliations":1005,"indexDatabases":1006,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1002,"title":1003},{"VOID":665},{"EN":667},[],[],[],{"volume":1008,"pages":1010},{"VOID":1009},"42",{"VOID":1011},"1-8","2006-01-01",2006,{"id":1015,"createTime":1016,"updateTime":1016,"relativeEntities":1017,"slug":1018,"properties":1019,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1025,"fullTextUrl":26,"authors":1026,"publicationType":747,"publisherRelationship":1275,"citationCount":26,"citationInfo":26,"publishDate":1289,"publishYear":1290,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"1517de81-de0e-4173-bcb4-5f01d1d3395b","2023-12-02T12:30:19.789+00:00",[],"Menopausia",{"references":1020,"title":1022,"doi":1023},{"VOID":1021},"Rousset-Jablonski, 2021, How to diagnose menopause? Postmenopausal women management : CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 318\nHarlow, 2007, Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging, Climacteric, 10, 112, 10.1080\u002F13697130701258838\nRandolph, 2003, Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status, J Clin Endocrinol Metab, 88, 1516, 10.1210\u002Fjc.2002-020777\nRandolph, 2011, Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period, J Clin Endocrinol Metab, 96, 746, 10.1210\u002Fjc.2010-1746\nFreeman, 2007, Association of anti-mullerian hormone levels with obesity in late reproductive-age women, Fertil Steril, 87, 101, 10.1016\u002Fj.fertnstert.2006.05.074\nGracia, 2005, The relationship between obesity and race on inhibin B during the menopause transition, Menopause, 12, 559, 10.1097\u002F01.gme.0000172268.24949.94\nHuddleston, 2010, Racial and ethnic disparities in reproductive endocrinology and infertility, Am J Obstet Gynecol, 202, 413, 10.1016\u002Fj.ajog.2009.12.020\nMaitrot-Mantelet, 2021, Differential diagnosis of vasomotor symptoms. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 329\nPalacios, 2015, Update on management of genitourinary syndrome of menopause: a practical guide, Maturitas, 82, 308, 10.1016\u002Fj.maturitas.2015.07.020\nFaubion, 2017, Genitourinary syndrome of menopause: management strategies for the clinician, Mayo Clin Proc, 92, 1842, 10.1016\u002Fj.mayocp.2017.08.019\nPortman, 2014, Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society, Menopause, 21, 1063, 10.1097\u002FGME.0000000000000329\nNappi, 2016, Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE survey, Climacteric, 19, 188, 10.3109\u002F13697137.2015.1107039\nLegendre, 2012, Urinary incontinence and menopause, Progr Urol, 22, 615, 10.1016\u002Fj.purol.2012.08.267\nGosset, 2021, Menopausal hormone therapy for the management of osteoporosis, Best Pract Res Clin Endocrinol Metab, 35, 10.1016\u002Fj.beem.2021.101551\nGrange L, Chales G, Alliot Launois F. Livre blanc des états généraux de l’ostéoporose 2016.\nPouillès, 2021, Menopause, menopause hormone therapy and osteoporosis. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 420\nBoulat, 2019, Principales évolutions de la mortalité par cause médicale sur la période 2000–2016 en France métropolitaine, Bull Epidemiol Hebd, 576\nLecoffre, 2017, L’accident vasculaire cérébral en France : patients hospitalisés pour AVC en 2014 et évolutions 2008–2014, Bull Epidemiol Hebd, 84\nGabet, 2016, Évolution temporelle du recours à la réadaptation cardiaque après un infarctus du myocarde, France, 2010–2014, Bull Epidemiol Hebd, 43, 764\nPlu-Bureau, 2021, Menopausal hormone therapy an cardiovascular risk. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 438\nHaute Autorité de santé. Cancer du sein : modalités de dépistage en fonction du risque 2014. www.has-sante.fr\u002Fjcms\u002Fpprd_2974673\u002Ffr\u002Fcancer-du-sein-modalites-specifiques-de-depistage-pour-les-femmes-a-haut-risque#toc_1_1_3.\nDuclos, 2021, Effects of physical activity and decreased sedentary behaviours in menopausal women. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 335\nLaCroix, 2017, The objective physical activity and cardiovascular disease health in older women (OPACH) study, BMC Public Health, 17, 192, 10.1186\u002Fs12889-017-4065-6\nAgence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail. Actualisation des repères du PNNS-révision des repères relatifs à l’activité physique et à la sédentarité; 2016.\nInstitut national de la santé et de la recherche médicale. Activité physique : prévention et traitement des maladies chroniques 2019.\nAmbikairajah, 2019, Fat mass changes during menopause: a meta-analysis, Am J Obstet Gynecol, 221, 393, 10.1016\u002Fj.ajog.2019.04.023\nHaute Autorité de santé. Guide de promotion, consultation et prescription médicale d’activité physique et sportive pour la santé chez les adultes 2018. www.has-sante.fr.\nLecerf, 2021, Nutritional advices for postmenopausal woman. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 349\nZiel, 1975, Increased risk of endometrial carcinoma among users of conjugated estrogens, N Engl J Med, 293, 1167, 10.1056\u002FNEJM197512042932303\nGrady, 1992, Hormone therapy to prevent disease and prolong life in postmenopausal women, Ann Intern Med, 117, 1016, 10.7326\u002F0003-4819-117-12-1016\nHulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\u002Fprogestin Replacement Study (HERS) Research Group, JAMA, 280, 605, 10.1001\u002Fjama.280.7.605\nRossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001\u002Fjama.288.3.321\nChlebowski, 2003, Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial, JAMA, 289, 3243, 10.1001\u002Fjama.289.24.3243\nBeral, 2019, Menopausal hormone therapy and 20-year breast cancer mortality, Lancet, 394, 1139, 10.1016\u002FS0140-6736(19)32033-1\nManson, 2013, Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials, JAMA, 310, 1353, 10.1001\u002Fjama.2013.278040\nManson, 2017, Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials, JAMA, 318, 927, 10.1001\u002Fjama.2017.11217\nBenkhadra, 2015, Menopausal hormone therapy and mortality: a systematic review and meta-analysis, J Clin Endocrinol Metab, 100, 4021, 10.1210\u002Fjc.2015-2238\nHa-Vinh, 2010, Individual factors and mortality associated with hormone replacement therapy in a French cohort of women from 60 to 69 years of age, J Gynecol Obstet Biol Reprod (Paris), 39, 453, 10.1016\u002Fj.jgyn.2010.06.006\nBoardman HM, Hartley L, Eisinga A, Main C, Figuls MR i, Cosp XB, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015;3:CD002229. Doi: 10.1002\u002F14651858.CD002229.pub4.\nSimin, 2017, Menopausal hormone therapy and cancer risk: an overestimated risk?, Eur J Cancer Oxf Engl, 84, 60, 10.1016\u002Fj.ejca.2017.07.012\nAnderson, 2004, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, 291, 1701, 10.1001\u002Fjama.291.14.1701\nCanonico, 2016, Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen, Stroke, 47, 1734, 10.1161\u002FSTROKEAHA.116.013052\nRovinski, 2018, Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis, Thromb Res, 168, 83, 10.1016\u002Fj.thromres.2018.06.014\nVinogradova, 2020, Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases, BMJ, 371, m3873, 10.1136\u002Fbmj.m3873\nCanonico, 2007, Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study, Circulation, 115, 840, 10.1161\u002FCIRCULATIONAHA.106.642280\nCanonico, 2010, Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study, Arterioscler Thromb Vasc Biol, 30, 340, 10.1161\u002FATVBAHA.109.196022\nScarabin, 2018, Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis, Climacteric, 21, 341, 10.1080\u002F13697137.2018.1446931\nCurb, 2006, Venous thrombosis and conjugated equine estrogen in women without a uterus, Arch Intern Med, 166, 772, 10.1001\u002Farchinte.166.7.772\nCushman, 2004, Estrogen plus progestin and risk of venous thrombosis, JAMA, 292, 1573, 10.1001\u002Fjama.292.13.1573\nCanonico, 2006, Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER study, J Thromb Haemost, 4, 1259, 10.1111\u002Fj.1538-7836.2006.01933.x\nSweetland, 2012, Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study, J Thromb Haemost, 10, 2277, 10.1111\u002Fj.1538-7836.2012.04919.x\nVinogradova, 2019, Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases, BMJ, 364, k4810, 10.1136\u002Fbmj.k4810\nPoudou, 2021, Benefit-risk balance of hormone replacement therapy: cancers and mortality. Postmenopausal women management - CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 462\nFournier, 2014, Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort, Breast Cancer Res Treat, 145, 535, 10.1007\u002Fs10549-014-2934-6\nCordina-Duverger, 2013, Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France, PloS One, 8, 10.1371\u002Fjournal.pone.0078016\nBeral, 2011, Breast cancer risk in relation to the interval between menopause and starting hormone therapy, J Natl Cancer Inst, 103, 296, 10.1093\u002Fjnci\u002Fdjq527\nBeral, 2003, Breast cancer and hormone-replacement therapy in the Million Women Study, Lancet, 362, 419, 10.1016\u002FS0140-6736(03)14065-2\nCollins, 2005, Breast cancer risk with postmenopausal hormonal treatment, Hum Reprod Update, 11, 545, 10.1093\u002Fhumupd\u002Fdmi028\nGrady, 1995, Hormone replacement therapy and endometrial cancer risk: a meta-analysis, Obstet Gynecol, 85, 304, 10.1016\u002F0029-7844(94)00383-O\nAllen, 2010, Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition, Am J Epidemiol, 172, 1394, 10.1093\u002Faje\u002Fkwq300\nBrinton, 2014, Menopausal hormone therapy and risk of endometrial cancer, J Steroid Biochem Mol Biol, 142, 83, 10.1016\u002Fj.jsbmb.2013.05.001\nBeresford, 1997, Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women, Lancet, 349, 458, 10.1016\u002FS0140-6736(96)07365-5\nJaakkola, 2009, Endometrial cancer in postmenopausal women using estradiol-progestin therapy, Obstet Gynecol, 114, 1197, 10.1097\u002FAOG.0b013e3181bea950\nFournier, 2014, Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008, Am J Epidemiol, 180, 508, 10.1093\u002Faje\u002Fkwu146\nLiu, 2019, Menopausal hormone replacement therapy and the risk of ovarian cancer: a meta-analysis, Front Endocrinol (Lausanne), 10, 801, 10.3389\u002Ffendo.2019.00801\nAvis, 2015, Duration of menopausal vasomotor symptoms over the menopause transition, JAMA Intern Med, 175, 531, 10.1001\u002Fjamainternmed.2014.8063\nRaccah-Tebeka, 2021, Non-hormonal alternatives for the management of menopausal hot flushes. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 373\nRance, 2013, Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes, Front Neuroendocrinol, 34, 211, 10.1016\u002Fj.yfrne.2013.07.003\nPrague, 2017, Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial, Lancet, 389, 1809, 10.1016\u002FS0140-6736(17)30823-1\nGosset, 2021, Menopause hormone treatment in practice. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 358\nDepypere, 2015, The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review, Climacteric, 18, 470, 10.3109\u002F13697137.2014.991302\nRaudaskoski, 2002, Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response, BJOG, 109, 136\nTrémollieres, 2021, Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines (short version), Gynecol Obstet Fertil Senol, 49, 305\nHaimov-Kochman, 2006, Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study, Menopause, 13, 370\nAslan, 2007, How best is to discontinue postmenopausal hormone therapy: immediate or tapered?, Maturitas, 56, 78, 10.1016\u002Fj.maturitas.2006.06.006\nLindh-Astrand, 2010, A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms, Menopause, 17, 72, 10.1097\u002Fgme.0b013e3181b397c7\nPerrone, 2013, Menopausal symptoms after the discontinuation of long-term hormone replacement therapy in women under 60: a 3-year follow-up, Gynecol Obstet Invest, 76, 38, 10.1159\u002F000351104\nMaclennan, 2004, Oral oestrogen and combined oestrogen\u002Fprogestogen therapy versus placebo for hot flushes, Cochrane Database Syst Rev, 4\nDesmarais, 2010, Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions, Maturitas, 67, 296, 10.1016\u002Fj.maturitas.2010.08.005\nHenry, 2008, Drug interactions and pharmacogenomics in the treatment of breast cancer and depression, Am J Psychiatry, 165, 1251, 10.1176\u002Fappi.ajp.2008.08040482\nLethaby, 2013, Phytoestrogens for menopausal vasomotor symptoms, Cochrane Database Syst Rev, 12, CD001395\nSrisukho, 2019, The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue, Int Urogynecol J, 30, 1843, 10.1007\u002Fs00192-019-03991-0\nSzymański, 2018, Genitourinary syndrome of menopause – is the problem solved? State of the art 2018, Prz Menopauzalny, 17, 168\nCastelo-Branco, 2005, Management of post-menopausal vaginal atrophy and atrophic vaginitis, Maturitas, 52, S46, 10.1016\u002Fj.maturitas.2005.06.014\nPinkerton, 2017, Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning, Maturitas, 100, 57, 10.1016\u002Fj.maturitas.2017.03.315\nBachmann, 2000, Diagnosis and treatment of atrophic vaginitis, Am Fam Physician, 61, 3090\nKarakoç, 2019, Genitourinary syndrome of menopause: effects on related factors, quality of life, and self-care power, Prz Menopauzalny, 18, 15\nPastore, 2004, Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative, Maturitas, 49, 292, 10.1016\u002Fj.maturitas.2004.06.019\nMac Bride, 2010, Vulvovaginal atrophy, Mayo Clin Proc, 85, 87, 10.4065\u002Fmcp.2009.0413\nCardozo, 1998, Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee, Obstet Gynecol, 92, 722\nBarnabei, 2005, Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative, Obstet Gynecol, 105, 1063, 10.1097\u002F01.AOG.0000158120.47542.18\nFantl, 1996, Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group, Obstet Gynecol, 88, 745, 10.1016\u002F0029-7844(96)00281-5\nRufford, 2003, A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women, Int Urogynecol J Pelvic Floor Dysfunct, 14, 78, 10.1007\u002Fs00192-003-1054-3\nSteinauer, 2005, Postmenopausal hormone therapy: does it cause incontinence?, Obstet Gynecol, 106, 940, 10.1097\u002F01.AOG.0000180394.08406.15\nHendrix, 2005, Effects of estrogen with and without progestin on urinary incontinence, JAMA, 293, 935, 10.1001\u002Fjama.293.8.935\nWaetjen, 2005, The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women, Obstet Gynecol, 106, 946, 10.1097\u002F01.AOG.0000182576.48290.6d\nSulaica, 2016, Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy, Breast Cancer Res Treat, 157, 203, 10.1007\u002Fs10549-016-3827-7\nMaris, 2021, Management of vulvovaginal atrophy: Physical therapies. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 414\nGambacciani, 2015, Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause, Climacteric, 18, 757, 10.3109\u002F13697137.2015.1045485\nGaspar, 2017, Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause, Lasers Surg Med, 49, 160, 10.1002\u002Flsm.22569\nCruz, 2018, Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women, Menopause, 25, 21, 10.1097\u002FGME.0000000000000955\nRuanphoo, 2020, Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial, Menopause, 27, 858, 10.1097\u002FGME.0000000000001542\nJha, 2019, The impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: a systematic review and meta-analysis, Clin Breast Cancer, 19, e556, 10.1016\u002Fj.clbc.2019.04.007\nPreti, 2019, The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: an ICS\u002FISSVD best practice consensus document, J Low Genit Tract Dis, 23, 151, 10.1097\u002FLGT.0000000000000462\nKanis, 2005, Assessment of fracture risk, Osteoporos Int, 16, 581, 10.1007\u002Fs00198-004-1780-5\nSornay-Rendu, 2014, How to predict fragility fracture beyond 10 years? The OFELY study, J Clin Endocrinol Metab, 99, 4690, 10.1210\u002Fjc.2014-2601\nLeslie, 2011, A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world, Curr Osteoporos Rep, 9, 129, 10.1007\u002Fs11914-011-0060-5\nBriot, 2018, 2018 update of French recommendations on the management of postmenopausal osteoporosis, Joint Bone Spine, 85, 519, 10.1016\u002Fj.jbspin.2018.02.009\nHaute Autorité de santé. Les médicaments de l’ostéoporose 2019.\nRiggs, 2004, Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites, J Bone Miner Res, 19, 1945, 10.1359\u002Fjbmr.040916\nSowers, 2013, Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity, J Clin Endocrinol Metab, 98, 2854, 10.1210\u002Fjc.2012-4113\nGRIO. Actualisation 2017 des recommandations de traitement de l’ostéoporosepost ménopausique 2017. www.grio.org\u002Fdocuments\u002Fpage240\u002Frecommandations-pmo-actualisation-2017.pdf.\nWeiss, 1999, A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group, Obstet Gynecol, 94, 330\nDelmas, 1999, A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group, Bone, 24, 517, 10.1016\u002FS8756-3282(99)00076-9\nHeikkinen, 2000, Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens, Osteoporos Int, 11, 929, 10.1007\u002Fs001980070031\nGartlehner, 2017, Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US Preventive Services Task Force, JAMA, 318, 2234, 10.1001\u002Fjama.2017.16952\nBanks, 2004, Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women, JAMA, 291, 2212, 10.1001\u002Fjama.291.18.2212\nWasnich, 2004, Changes in bone density and turnover after alendronate or estrogen withdrawal, Menopause, 11, 622, 10.1097\u002F01.GME.0000123641.76105.B5\nGallagher, 2002, Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers, J Clin Endocrinol Metab, 87, 4914, 10.1210\u002Fjc.2002-020727\nHocké, 2021, Syndrome génito-urinaire de la ménopause (SGUM). RPC les femmes ménopausées du CNGOF et du GEMVi, Gynecol Obstr Fertil Senol, 49, 394",{"ES":1018},{"VOID":1024},"10.1016\u002Fs1283-081x(23)47976-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X23479763",[1027,1042,1054,1066,1078,1090,1102,1114,1126,1138,1155,1167,1179,1191,1203,1215,1227,1239,1251,1263],{"id":1028,"sortIndex":135,"researcher":26,"roles":1029,"affiliations":1030,"properties":1039},"ff39c540-6905-45c7-ba30-f671547b2723",[696],[1031],{"id":26,"sortIndex":36,"affiliation":1032,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1035,"slug":26,"properties":1036,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6c598c7e-c70e-4873-95d3-10c61b40e56a","2023-12-02T12:30:19.889+00:00",[],{"title":1037},{"VI":1038},"Collège national des gynécologues et obstétriciens français, Groupe d’étude sur la ménopause et le vieillissement hormonal, Groupe de travail « Recommandation pour la pratique Clinique 2021: les femmes ménopausées », Paris, France",{"title":1040},{"VI":1041},"J.-M. Pouille",{"id":1043,"sortIndex":51,"researcher":26,"roles":1044,"affiliations":1045,"properties":1051},"716f2bd8-4a87-4c40-aaba-8ed515a100e8",[696],[1046],{"id":26,"sortIndex":36,"affiliation":1047,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1048,"slug":26,"properties":1049,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1050},{"VI":1038},{"title":1052},{"VI":1053},"N. Hamdaoui",{"id":1055,"sortIndex":53,"researcher":26,"roles":1056,"affiliations":1057,"properties":1063},"db0da6bd-a139-4ccc-ab33-5d353c7a1b2e",[696],[1058],{"id":26,"sortIndex":36,"affiliation":1059,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1060,"slug":26,"properties":1061,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1062},{"VI":1038},{"title":1064},{"VI":1065},"J. Hugon-Rodin",{"id":1067,"sortIndex":298,"researcher":26,"roles":1068,"affiliations":1069,"properties":1075},"6d30f934-d7f9-4283-9612-ac3aba3cfb0e",[696],[1070],{"id":26,"sortIndex":36,"affiliation":1071,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1072,"slug":26,"properties":1073,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1074},{"VI":1038},{"title":1076},{"VI":1077},"G. André",{"id":1079,"sortIndex":162,"researcher":26,"roles":1080,"affiliations":1081,"properties":1087},"601a1d29-553e-4a98-a5c5-7423aac86e0e",[696],[1082],{"id":26,"sortIndex":36,"affiliation":1083,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1084,"slug":26,"properties":1085,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1086},{"VI":1038},{"title":1088},{"VI":1089},"M. Duclos",{"id":1091,"sortIndex":173,"researcher":26,"roles":1092,"affiliations":1093,"properties":1099},"adb5c12d-9967-4da2-ae28-90f05034e0fe",[696],[1094],{"id":26,"sortIndex":36,"affiliation":1095,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1096,"slug":26,"properties":1097,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1098},{"VI":1038},{"title":1100},{"VI":1101},"X. Fritel",{"id":1103,"sortIndex":234,"researcher":26,"roles":1104,"affiliations":1105,"properties":1111},"48101ac1-40be-472b-979e-d0c0e14b44b2",[696],[1106],{"id":26,"sortIndex":36,"affiliation":1107,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1108,"slug":26,"properties":1109,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1110},{"VI":1038},{"title":1112},{"VI":1113},"O. Graesslin",{"id":1115,"sortIndex":336,"researcher":26,"roles":1116,"affiliations":1117,"properties":1123},"263ebcd7-675f-479a-b53d-d03642cb5a95",[696],[1118],{"id":26,"sortIndex":36,"affiliation":1119,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1120,"slug":26,"properties":1121,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1122},{"VI":1038},{"title":1124},{"VI":1125},"C. Mathelin",{"id":1127,"sortIndex":158,"researcher":26,"roles":1128,"affiliations":1129,"properties":1135},"527bbe33-b750-4d3c-b958-7a4a44069cd1",[696],[1130],{"id":26,"sortIndex":36,"affiliation":1131,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1132,"slug":26,"properties":1133,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1134},{"VI":1038},{"title":1136},{"VI":1137},"A. Gosset",{"id":1139,"sortIndex":36,"researcher":26,"roles":1140,"affiliations":1141,"properties":1152},"1778a412-5429-47f6-b380-130f2196a836",[696],[1142],{"id":26,"sortIndex":36,"affiliation":1143,"properties":26},{"id":1144,"createTime":1145,"updateTime":1146,"relativeEntities":1147,"slug":1148,"properties":1149,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"0523ed73-f6f8-4b89-9ae5-2f5e91940931","2023-12-02T12:30:19.804+00:00","2025-06-11T18:20:31.093+00:00",[],"Service-de-gyn%C3%A9cologie-obst%C3%A9trique-m%C3%A9decine-de-la-reproduction-H%C3%B4pital-Tenon-AP-HP-Sorbonne-Universit%C3%A9-4-rue-de-la-Chine-75020-Paris-France",{"title":1150},{"VI":1151},"Service de gynécologie obstétrique médecine de la reproduction, Hôpital Tenon, AP–HP, Sorbonne Université, 4 rue de la Chine, 75020 Paris, France",{"title":1153},{"VI":1154},"N. Chabbert-Buffet",{"id":1156,"sortIndex":59,"researcher":26,"roles":1157,"affiliations":1158,"properties":1164},"a16e47f4-64e1-414f-96f9-f8b4be1318e1",[696],[1159],{"id":26,"sortIndex":36,"affiliation":1160,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1161,"slug":26,"properties":1162,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1163},{"VI":1038},{"title":1165},{"VI":1166},"C. Rousset-Jablonski",{"id":1168,"sortIndex":124,"researcher":26,"roles":1169,"affiliations":1170,"properties":1176},"2df716cb-0ba4-4e19-afa4-b9f7208f1bad",[696],[1171],{"id":26,"sortIndex":36,"affiliation":1172,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1173,"slug":26,"properties":1174,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1175},{"VI":1038},{"title":1177},{"VI":1178},"P. Lopes",{"id":1180,"sortIndex":116,"researcher":26,"roles":1181,"affiliations":1182,"properties":1188},"d04c02cd-1fab-4835-b3b9-dc4fccecd5d5",[696],[1183],{"id":26,"sortIndex":36,"affiliation":1184,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1185,"slug":26,"properties":1186,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1187},{"VI":1038},{"title":1189},{"VI":1190},"E. Maris",{"id":1192,"sortIndex":114,"researcher":26,"roles":1193,"affiliations":1194,"properties":1200},"4db97be7-9be9-4075-b6e0-4c5b6a374750",[696],[1195],{"id":26,"sortIndex":36,"affiliation":1196,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1197,"slug":26,"properties":1198,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1199},{"VI":1038},{"title":1201},{"VI":1202},"G. Plu-Bureau",{"id":1204,"sortIndex":111,"researcher":26,"roles":1205,"affiliations":1206,"properties":1212},"8329402b-35cf-4eb6-b7dd-aa8527e8ee2a",[696],[1207],{"id":26,"sortIndex":36,"affiliation":1208,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1209,"slug":26,"properties":1210,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1211},{"VI":1038},{"title":1213},{"VI":1214},"J.-M. Lecerf",{"id":1216,"sortIndex":115,"researcher":26,"roles":1217,"affiliations":1218,"properties":1224},"7267bb95-824a-475c-bf1c-9773b9a59886",[696],[1219],{"id":26,"sortIndex":36,"affiliation":1220,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1221,"slug":26,"properties":1222,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1223},{"VI":1038},{"title":1225},{"VI":1226},"F. Trémollieres",{"id":1228,"sortIndex":356,"researcher":26,"roles":1229,"affiliations":1230,"properties":1236},"20d4868c-d9e8-4eae-bd04-032e8f16942e",[696],[1231],{"id":26,"sortIndex":36,"affiliation":1232,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1233,"slug":26,"properties":1234,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1235},{"VI":1038},{"title":1237},{"VI":1238},"G. Robin",{"id":1240,"sortIndex":103,"researcher":26,"roles":1241,"affiliations":1242,"properties":1248},"831a096c-14b8-429b-97de-3fcf4b95f1b5",[696],[1243],{"id":26,"sortIndex":36,"affiliation":1244,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1245,"slug":26,"properties":1246,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1247},{"VI":1038},{"title":1249},{"VI":1250},"L. Maitrot-Mantelet",{"id":1252,"sortIndex":50,"researcher":26,"roles":1253,"affiliations":1254,"properties":1260},"44247774-6183-48ef-9860-738229f683b6",[696],[1255],{"id":26,"sortIndex":36,"affiliation":1256,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1257,"slug":26,"properties":1258,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1259},{"VI":1038},{"title":1261},{"VI":1262},"G. Boutet",{"id":1264,"sortIndex":52,"researcher":26,"roles":1265,"affiliations":1266,"properties":1272},"c151b938-5903-41bb-ac5c-c59a7172515b",[696],[1267],{"id":26,"sortIndex":36,"affiliation":1268,"properties":26},{"id":1033,"createTime":1034,"updateTime":1034,"relativeEntities":1269,"slug":26,"properties":1270,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1271},{"VI":1038},{"title":1273},{"VI":1274},"C. Hocké",{"url":1025,"publisher":1276,"properties":1284},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1277,"slug":662,"properties":1278,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1281,"manageAffiliations":1282,"indexDatabases":1283,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1279,"title":1280},{"VOID":665},{"EN":667},[],[],[],{"volume":1285,"pages":1287},{"VOID":1286},"59",{"VOID":1288},"1-13","2023-09-01",2023,{"id":1292,"createTime":1293,"updateTime":1293,"relativeEntities":1294,"slug":1295,"properties":1296,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1303,"fullTextUrl":26,"authors":1304,"publicationType":747,"publisherRelationship":1350,"citationCount":26,"citationInfo":26,"publishDate":1363,"publishYear":1364,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"a1761522-6120-48d3-bcb7-4a62c847c458","2023-11-30T06:21:53.407+00:00",[],"F%C3%A1rmacos-tocol%C3%ADticos",{"references":1297,"title":1299,"doi":1301},{"VOID":1298},"Sentilhes, 2016, Recommandations pour la pratique clinique : prévention de la prématurité spontanée et de ses conséquences (hors rupture des membranes) –Texte des recommandations, J Gynecol Obstet Biol Reprod, 45, 1446, 10.1016\u002Fj.jgyn.2016.09.011\nDoret, 2016, La tocolyse en cas de menace d’accouchement prématuré à membranes intactes, J Gynecol Obstet Biol Reprod, 45, 1374, 10.1016\u002Fj.jgyn.2016.09.018\nNeilson, 2014, Betamimetics for inhibiting preterm labour, Cochrane Database Syst Rev, CD004352\nHaas, 2012, Tocolytic therapy for preterm delivery: systematic review and network meta-analysis, BMJ, 345, e6226, 10.1136\u002Fbmj.e6226\nFlenady, 2014, Oxytocin receptor antagonists for inhibiting preterm labour, Cochrane Database Syst Rev, CD004452\nHaas, 2009, Tocolytic therapy: a meta-analysis and decision analysis, Obstet Gynecol, 113, 585, 10.1097\u002FAOG.0b013e318199924a\nConde-Agudelo, 2011, Nifedipine in the management of preterm labor: a systematic review and meta-analysis, Am J Obstet Gynecol, 204, 10.1016\u002Fj.ajog.2010.11.038\nTsatsaris, 2001, Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis, Obstet Gynecol, 97, 840\nCoomarasamy, 2002, Oxytocin antagonists for tocolysis in preterm labour -- a systematic review, Med Sci Monit, 8, RA268\nLeveno, 1986, Single-centre randomised trial of ritodrine hydrochloride for preterm labour, Lancet, 1, 1293, 10.1016\u002FS0140-6736(86)91219-5\nde Heus, 2009, Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study, BMJ, 338, b744, 10.1136\u002Fbmj.b744\nMabie, 1983, Pulmonary edema induced by betamimetic drugs, South Med J, 76, 1354, 10.1097\u002F00007611-198311000-00007\nDudenhausen, 2006, “Normal” pregnancy with adverse events on initial tocolytic treatment, BJOG, 113, 116, 10.1111\u002Fj.1471-0528.2006.01138.x\nPaternoster, 2004, Maternal complications from tocolytic treatment with ritodrine. Three cases of pulmonary edema, Minerva Ginecol, 56, 491\nKaraman, 2004, Pulmonary edema after ritodrine therapy during pregnancy and subsequent cesarean section with epidural anesthesia, Clin Exp Obstet Gynecol, 31, 67\nHamel, 2002, [Pulmonary edema and tocolysis with beta-agonists], Rev Mal Respir, 19, 241\nMilos, 1988, Maternal pulmonary edema complicating beta-adrenergic therapy of preterm labor, AJR Am J Roentgenol, 151, 917, 10.2214\u002Fajr.151.5.917\nEvron, 1983, [Pulmonary edema occurring after isoxsuprine treatment for preterm labor], Harefuah, 105, 287\nBenedetti, 1982, Maternal pulmonary edema during premature labor inhibition, Obstet Gynecol, 59\nStubblefield, 1978, Pulmonary edema occurring after therapy with dexamethasone and terbutaline for premature labor: a case report, Am J Obstet Gynecol, 132, 341, 10.1016\u002F0002-9378(78)90907-9\nNagey, 1982, Pulmonary complications of isoxsuprine therapy in the gravida, Obstet Gynecol, 59\nJacobs, 1980, Maternal pulmonary edema resulting from betamimetic and glucocorticoid therapy, Obstet Gynecol, 56, 56\nGuernsey, 1981, Pulmonary edema associated with the use of betamimetic agents in preterm labor, Am J Hosp Pharm, 38, 1942\nBrosset, 1982, Cardiac complications of ritodrine in mother and baby, Lancet, 1, 1468, 10.1016\u002FS0140-6736(82)92476-X\nCarson, 2002, Atrial fibrillation in pregnancy associated with oral terbutaline, Obstet Gynecol, 100, 1096\nAbramovici, 1980, Maternal pulmonary edema occurring after therapy with ritodrine for premature uterine contractions, Acta Obstet Gynecol Scand, 59, 555, 10.3109\u002F00016348009155450\nDordević, 2002, [Successful resuscitation of a patient with prolonged tocolytic therapy and an emergency cesarean section], Vojnosanit Pregl, 59, 325, 10.2298\u002FVSP0203325D\nMagnus, 1987, [Myocardial infarction during tocolysis with sympathomimetics], Tidsskr Nor Laegeforen, 107, 943\nKotoujansky, 1985, [Tocolysis using salbutamol in cases of cardiac rhythm disorders in the mother. Apropos of 4 cases], J Gynecol Obstet Biol Reprod, 14, 915\nZhang, 2014, Ritodrine-induced agranulocytosis in pregnancy, J Obstet Gynaecol, 34, 533, 10.3109\u002F01443615.2014.914481\nYasuda, 2012, Agranulocytosis associated with intravenous ritodrine hydrochloride therapy: two case reports by different mechanisms, J Obstet Gynaecol Res, 38, 574, 10.1111\u002Fj.1447-0756.2011.01756.x\nKikkawa, 2008, Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia, J Obstet Gynaecol Res, 34, 286, 10.1111\u002Fj.1447-0756.2008.00773.x\nMuro, 1991, Ritodrine-induced agranulocytosis, Int J Gynaecol Obstet, 36, 329, 10.1016\u002F0020-7292(91)90488-Q\nVerriello, 2009, Rhabdomyolysis caused by tocolytic therapy with ritodrine hydrochloride, Neuromuscul Disord, 19, 718, 10.1016\u002Fj.nmd.2009.06.364\nNasu, 2006, Rhabdomyolysis caused by tocolysis with oral ritodrine hydrochloride in a pregnant patient with myotonic dystrophy, Gynecol Obstet Invest, 1, 53, 10.1159\u002F000088531\nRosene, 1982, Cerebral ischemia associated with parenteral terbutaline use in pregnant migraine patients, Am J Obstet Gynecol, 143, 405, 10.1016\u002F0002-9378(82)90081-3\nHudgens, 1993, Sudden death associated with terbutaline sulfate administration, Am J Obstet Gynecol, 169, 120, 10.1016\u002F0002-9378(93)90144-8\nMilliez, 1980, A case report of maternal death associated with betamimetics and betamethasone administration in premature labor, Eur J Obstet Gynecol Reprod Biol, 11, 95, 10.1016\u002F0028-2243(80)90014-3\nRäsänen, 1990, The effects of ritodrine infusion on fetal myocardial function and fetal hemodynamics, Acta Obstet Gynecol Scand, 69, 487, 10.3109\u002F00016349009013323\nGokay, 2001, Changes in fetal hemodynamics with ritodrine tocolysis, Ultrasound Obstet Gynecol, 18, 44, 10.1046\u002Fj.1469-0705.2001.00453.x\nBrar, 1988, Maternal and fetal blood flow velocity waveforms in patients with preterm labor: effect of tocolytics, Obstet Gynecol, 72, 209\nWitter, 2009, In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes, Am J Obstet Gynecol, 201, 553, 10.1016\u002Fj.ajog.2009.07.010\nConnors, 2005, Beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins, J Child Neurol, 20, 876, 10.1177\u002F08830738050200110401\nPitzer, 2001, Child development after maternal tocolysis with beta-sympathomimetic drugs, Child Psychiatry Hum Dev, 31, 165, 10.1023\u002FA:1026419720410\nHadders-Algra, 1986, Long-term follow-up of children prenatally exposed to ritodrine, Br J Obstet Gynaecol, 93, 156, 10.1111\u002Fj.1471-0528.1986.tb07880.x\nFreysz, 1977, A long term evaluation of infants who received a beta-mimetic drug while in utero, J Perinat Med, 5, 94, 10.1515\u002Fjpme.1977.5.2.94\nGidaya, 2016, In utero exposure to β-2-adrenergic receptor agonist drugs and risk for autism spectrum disorders, Pediatrics, 137, e20151316, 10.1542\u002Fpeds.2015-1316\nNICE. Preterm Labour and Birth [Internet]. London: National Institute for Health and Care Excellence (UK); 2015.\nRomero, 2000, An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue, Am J Obstet Gynecol, 182, 1173, 10.1067\u002Fmob.2000.95834\nvan Vliet, 2016, Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial, Lancet, 387, 2117, 10.1016\u002FS0140-6736(16)00548-1\nAl-Omari, 2006, Atosiban and nifedipine in acute tocolysis: a comparative study, Eur J Obstet Gynecol Reprod Biol, 128, 129, 10.1016\u002Fj.ejogrb.2005.12.010\nSalim, 2012, Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial, Obstet Gynecol, 120, 1323, 10.1097\u002FAOG.0b013e3182755dff\nSeinen, 2013, [Maternal pulmonary oedema due to the use of atosiban in cases of multiple gestation], Ned Tijdschr Geneeskd, 157, A5316\nFernández, 2011, Severe non-cardiogenic pulmonary oedema secondary to atosiban and steroids, Int J Obstet Anesth, 20, 189, 10.1016\u002Fj.ijoa.2010.09.003\nFerguson, 1990, A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome, Am J Obstet Gynecol, 163, 105, 10.1016\u002FS0002-9378(11)90679-6\nSilberschmidt, 2008, Nifedipine concentration in maternal and umbilical cord blood after nifedipine gastrointestinal therapeutic system for tocolysis, BJOG, 115, 480, 10.1111\u002Fj.1471-0528.2007.01630.x\nClouqueur, 2015, [Adverse effects of calcium channels blockers used as tocolytic treatment], J Gynecol Obstet Biol Reprod, 44, 341, 10.1016\u002Fj.jgyn.2014.12.012\nFlenady, 2014, Calcium channel blockers for inhibiting preterm labour and birth, Cochrane Database Syst Rev, CD002255\nAra, 2008, A prospective randomised trial of nifedipine versus placebo in preterm labour, Bangladesh J Obstet Gynaecol, 23, 61, 10.3329\u002Fbjog.v23i2.4962\nZhang, 2002, [Clinical observations on the prevention and treatment of premature labor with nifedipine], Hua Xi Yi Ke Da Xue Xue Bao, 33, 288\nBejan-Angoulvant, 2015, [Calcium channel blockers pharmacology and their use as tocolytics], J Gynecol Obstet Biol Reprod, 44, 305, 10.1016\u002Fj.jgyn.2014.12.010\nParant, 2015, [Use of calcium channel blockers (CCB) for tocolysis in France and abroad], J Gynecol Obstet Biol Reprod, 44, 312, 10.1016\u002Fj.jgyn.2014.12.016\nLe Ray, 2010, [Nifedipine or nicardipine in management of threatened preterm delivery: an observational population-based study], J Gynecol Obstet Biol Reprod, 39, 490, 10.1016\u002Fj.jgyn.2010.04.004\nLaas, 2012, [Comparison of the rate of maternal complications of nifedipine and nicardipine in cases of preterm labor: historical study on two consecutive periods], J Gynecol Obstet Biol Reprod, 41, 631, 10.1016\u002Fj.jgyn.2012.04.020\nMcGuirl J, Arzuaga B, Lee BH. Antenatal calcium channel blocker exposure and subsequent patent ductus arteriosus in extremely low-birth-weight infants. Pediatr Cardiol 2012;33:60–4.\nSmith, 2007, Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor, Am J Obstet Gynecol, 196, 10.1016\u002Fj.ajog.2006.10.868\nHaghighi, 2005, Isosorbide dinitrate for treatment of preterm labor, Int J Gynaecol Obstet, 89, 274, 10.1016\u002Fj.ijgo.2005.03.004\nDuckitt, 2014, Nitric oxide donors for treating preterm labour, Cochrane Database Syst Rev, CD002860\nAmorim, 2009, [Transdermal nitroglycerin versus oral nifedipine administration for tocolysis: a randomized clinical trial], Rev Bras Ginecol Obstet, 31, 552\nCrowther, 2014, Magnesium sulphate for preventing preterm birth in threatened preterm labour, Cochrane Database Syst Rev, CD001060\nReinebrant, 2015, Cyclo-oxygenase (COX) inhibitors for treating preterm labour, Cochrane Database Syst Rev, CD001992\nErny, 1986, The effects of oral administration of progesterone for premature labor, Am J Obstet Gynecol, 154, 525, 10.1016\u002F0002-9378(86)90595-8\nChawanpaiboon, 2011, Comparison of success rate of nifedipine, progesterone, and bed rest for inhibiting uterine contraction in threatened preterm labor, J Obstet Gynaecol Res, 37, 787, 10.1111\u002Fj.1447-0756.2010.01434.x\nSu, 2014, Progestational agents for treating threatened or established preterm labour, Cochrane Database Syst Rev, CD006770\nKCE. Prévention de l’accouchement prématuré chez les femmes à risque – Évaluation de quelques mesures courantes. https:\u002F\u002Fkce.fgov.be\u002Ffr\u002Fpr%C3%A9vention-de-l%E2%80%99accouchement-pr%C3%A9matur%C3%A9-chez-les-femmes-%C3%A0-risque-%E2%80%93-evaluation-de-quelques-mesures.\n[No authors listed]. Practice Bulletin No. 159: Management of Preterm Labor. Obstet Gynecol 2016;127:e29–38.\nOrganisation mondiale de la santé. Recommandations de l’OMS sur les interventions visant à améliorer l’issue des naissances prématurées. Août 2015. http:\u002F\u002Fapps.who.int\u002Firis\u002Fbitstream\u002F10665\u002F200219\u002F1\u002FWHO_RHR_15.16_fre.pdf?ua=1.\nVeille, 1985, Maternal cardiovascular adaptations to twin pregnancy, Am J Obstet Gynecol, 153, 261, 10.1016\u002FS0002-9378(85)80109-5\nDodd, 2012, Oral betamimetics for maintenance therapy after threatened preterm labour, Cochrane Database Syst Rev, 12, CD003927\nChawanpaiboon, 2014, Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes, Cochrane Database Syst Rev, CD010800\nHan, 2013, Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD000940\nNaik Gaunekar, 2013, Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD004071\nRoos, 2013, Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial, JAMA, 309, 41, 10.1001\u002Fjama.2012.153817\nParry, 2014, The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour, Aust N Z J Obstet Gynaecol, 54, 231, 10.1111\u002Fajo.12179\nPapatsonis, 2013, Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD005938\nVogel, 2014, Combination of tocolytic agents for inhibiting preterm labour, Cochrane Database Syst Rev, CD006169\nManuck, 2015, Tocolysis for women with early spontaneous preterm labor and advanced cervical dilation, Obstet Gynecol, 126, 954, 10.1097\u002FAOG.0000000000001095\nde Veciana, 1995, Tocolysis in advanced preterm labor: impact on neonatal outcome, Am J Perinatol, 12, 294, 10.1055\u002Fs-2007-994478\nAmon, 2000, Tocolysis with advanced cervical dilatation, Obstet Gynecol, 95, 358\nKlauser, 2016, Tocolysis in women with advanced preterm labor: a secondary analysis of a randomized clinical trial, J Matern Fetal Neonatal Med, 29, 696, 10.3109\u002F14767058.2015.1018171",{"ES":1300},"Fármacos tocolíticos",{"VOID":1302},"10.1016\u002Fs1283-081x(19)42003-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X19420031",[1305,1320,1335],{"id":1306,"sortIndex":36,"researcher":26,"roles":1307,"affiliations":1308,"properties":1317},"b43820b1-e054-4ee3-ac76-3d9ee61394fc",[696],[1309],{"id":26,"sortIndex":36,"affiliation":1310,"properties":26},{"id":1311,"createTime":1312,"updateTime":1312,"relativeEntities":1313,"slug":26,"properties":1314,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"28f2c27d-a0a5-47ac-889a-e2fbc3dcd77a","2023-11-30T06:21:53.446+00:00",[],{"title":1315},{"VI":1316},"Service de gynécologie obstétrique, Hôpital Femme-Mère-Enfant, Hospices civils de Lyon, 59, boulevard Pinel, 69677 Bron cedex, France",{"title":1318},{"VI":1319},"M. Doret",{"id":1321,"sortIndex":115,"researcher":26,"roles":1322,"affiliations":1323,"properties":1332},"5319dc5e-c1f6-44cb-b32a-142b758b5503",[696],[1324],{"id":26,"sortIndex":36,"affiliation":1325,"properties":26},{"id":1326,"createTime":1327,"updateTime":1327,"relativeEntities":1328,"slug":26,"properties":1329,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"20b165d4-879a-440b-aff8-f3bb9f981f1d","2023-11-30T06:21:53.467+00:00",[],{"title":1330},{"VI":1331},"Service de gynécologie-obstétrique, Hôpital Trousseau, AP–HP, Paris, France",{"title":1333},{"VI":1334},"G. Kayem",{"id":1336,"sortIndex":114,"researcher":26,"roles":1337,"affiliations":1338,"properties":1347},"112b2d8a-62db-4ba9-8b3a-0c80b10d7b98",[696],[1339],{"id":26,"sortIndex":36,"affiliation":1340,"properties":26},{"id":1341,"createTime":1342,"updateTime":1342,"relativeEntities":1343,"slug":26,"properties":1344,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4c570d3a-0ed7-4288-ab4e-2ec370f4f17a","2023-11-30T06:21:53.515+00:00",[],{"title":1345},{"VI":1346},"Service de gynécologie-obstétrique, Hôpital Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France",{"title":1348},{"VI":1349},"L. Sentilhes",{"url":1303,"publisher":1351,"properties":1359},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1352,"slug":662,"properties":1353,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1356,"manageAffiliations":1357,"indexDatabases":1358,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1354,"title":1355},{"VOID":665},{"EN":667},[],[],[],{"volume":1360,"pages":1362},{"VOID":1361},"55",{"VOID":1011},"2019-06-01",2019,{"id":1366,"createTime":1367,"updateTime":1368,"relativeEntities":1369,"slug":1370,"properties":1371,"entityType":688,"verifyStatus":25,"verifyTime":1368,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1378,"fullTextUrl":26,"authors":1379,"publicationType":747,"publisherRelationship":1446,"citationCount":26,"citationInfo":26,"publishDate":1458,"publishYear":765,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"ae90fcaa-5b47-44a7-8ecb-e4c0580df982","2024-01-16T22:01:37.077+00:00","2024-12-24T17:45:08.683+00:00",[],"Presentaciones-en-extensi%C3%B3n",{"references":1372,"title":1374,"doi":1376},{"VOID":1373},"Audra P, Thoulon JM, Balsan M. Présentation de la face. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-049-L-20, 1997.\nBourgeois L. Observations diverses sur la stérilité, perte de fruict, fœcondité, accouchements et maladies des femmes et des enfants nouveaux-nés. 1609.\nMauriceau F. Traité des maladies des femmes grosses 1668. https:\u002F\u002Fgallica.bnf.fr\u002Fark:\u002F12148\u002Fbpt6k553 texteImage. 2783\nBaudelocque JL. Principes de l’art des accouchements. 1787.\nDe La Chapelle ML. Pratique des accouchements. 1821-1825.\nDumont, 1962, Les présentations de la face, Gynecol Obstet, 61, 684\nZayed, 2008, Face and brow presentation in northern Jordan, over a decade of experience, Arch Gynecol Obstet, 278, 427, 10.1007\u002Fs00404-008-0600-0\nTapisiz, 2014, Face presentation at term: a forgotten issue, J Obstet Gynaecol Res, 40, 1573, 10.1111\u002Fjog.12369\nCruishank, 1981, Face and brow presentation, a review, Clin Obstet Gynecol, 24, 333, 10.1097\u002F00003081-198106000-00003\nDucarme, 2006, Présentation de la face : étude rétrospective de 32 cas à terme, Gynecol Obstet Fertil, 34, 393, 10.1016\u002Fj.gyobfe.2005.07.042\nWestgren, 1984, Face presentation in modern obstetrics – A study with special reference to fetal long term morbidity, Z Geburtshilfe Perinatol, 188, 87\nBalsan M. La présentation de la face à propos de 24 observations. Besançon, 1994.\nQuiel, 1991, Gesichtslagengeburten, Zentralbl Gynakol, 113, 1380\nThoulon, 1971, La présentation de la face, Rev Fr Gynecol Obstet, 66, 231\nChaoui, 1982, La présentation de la face, J Gynecol Obstet Biol Reprod, 11, 731\nBenedetti, 1980, Face presentation at term, Obstet Gynecol, 55, 199\nDuff, 1981, Diagnosis and management of face presentation, Obstet Gynecol, 57, 105\nAudra, 1988, Les présentations céphaliques défléchies. À propos de 80 observations, Rev Fr Gynecol Obstet, 83, 355\nShaffer, 2006, Face presentation: predictors and delivery route, Am J Obstet Gynecol, 194, e10, 10.1016\u002Fj.ajog.2005.11.029\nBhal, 1998, A population study of face and brow presentation, J Obstet Gynaecol, 18, 231, 10.1080\u002F01443619867371\nDumont, 1968, Les présentations du front (étude de 29 observations et comparaisons de deux séries de cas recueillis entre 1949-1954 et 1955-1966), Rev Fr Gynecol Obstet, 63, 225\nEijskoot, 1977, An ultrasonic device for continuous measurement of cervical dilation during labor, Ultrasonics, 15, 183, 10.1016\u002F0041-624X(77)90052-X\nFloberg, 1987, Influence of the pelvic outlet capacity on fetal head presentation at delivery, Acta Obstet Gynecol Scand, 66, 127, 10.3109\u002F00016348709083033\nMostar, 1966, Deflexion attitudes Median vertex persistent, brow, and face presentations, Obstet Gynecol, 28, 49\nPosner, 1943, Face and persistant brow presentation, Surg Gynecol Obstet, 77, 618\nPosner, 1975, Modern trends in the management of face and brow presentation, Surg Gynecol Obstet, 104, 485\nReddoch, 1948, Face presentation, Am J Obstet Gynecol, 56, 86, 10.1016\u002F0002-9378(48)90192-6\nPrevedourakis, 1966, Face presentation. An analysis of 163 cases, Am J Obstet Gynecol, 94, 1092, 10.1016\u002F0002-9378(66)90770-8\nRudolph, 1947, Face presentation, Am J Obstet Gynecol, 54, 987, 10.1016\u002FS0002-9378(16)39712-5\nJacobson, 1962, Brow face presentations, Am J Obstet Gynecol, 84, 1881, 10.1016\u002F0002-9378(62)90478-7\nMorris, 1953, Face brow presentations, J Obstet Gynaecol Br Emp, 60, 44, 10.1111\u002Fj.1471-0528.1953.tb06410.x\nArsene, 2016, Prenatal factors related to face presentation: a case-control study, Arch Gynecol Obstet, 294, 279, 10.1007\u002Fs00404-015-3992-7\nHellman, 1950, Face and brow presentations, Am J Obstet Gynecol, 59, 831, 10.1016\u002F0002-9378(50)90113-X\nFloberg, 1987, Influence of pelvic outlet capacity on labor. A prospective pelvimetry study of 1,429 unselected primiparas, Acta Obstet Gynecol Scand, 66, 121, 10.3109\u002F00016348709083032\nDede, 1963, Face presentation, Am J Obstet Gynecol, 87, 515, 10.1016\u002F0002-9378(63)90563-5\nIngoldsson, 1969, Brow presentation, Acta Obstet Gynecol Scand, 48, 486, 10.3109\u002F00016346909156664\nMandoul, 1983, Diagnostic anténatal d’une tumeur du cou par échographie, JEMU, 4, 155\nRuf, 1962, Déflexion primitive de la tête, Bull Fed Gynecol Obstet, 14, 171\nBorell, 1960, The mecanism of labour in face and brow presentation a radiologic study, Acta Obstet Gynecol Scand, 39, 626, 10.3109\u002F00016346009155741\nLau, 2009, Intrapartum translabial ultrasound demonstrating brow presentation during the second stage of labor, Int J Gynaecol Obstet, 107, 62, 10.1016\u002Fj.ijgo.2009.05.024\nNeuman, 1994, Intrapartum bimanual tocolytic-assisted reversal of face presentation: Preliminary report, Obstet Gynecol, 84, 146\nWhitacre, 1965, Forceps management of breech and face presentations, Clin Obstet Gynecol, 8, 882, 10.1097\u002F00003081-196512000-00007\nOffringa, 2019, Spatulas for entrapment of the after-coming head during vaginal breech delivery, Arch Gynecol Obstet, 299, 1283, 10.1007\u002Fs00404-019-05115-x\nDe Bernardo, 2017, Face presentation in delivery room: what is strategy?, BMJ Case Rep, 2017\nÖzdemir, 2018, Lip and face edema due to face presentation, J Pediatr Res, 5, 52, 10.4274\u002Fjpr.63626\nAudra, 1988, Monitoring of pregnancy and delivery in women over 40, Soins Gynecol Obstet Pueric Pediatr, 18\nThoulon, 1971, Transformation spontanée d’une attitude défléchie (front primitif en sommet dans les derniers mois de la grossesse), Bull Fed Gynecol Obstet, 23, 620\nLuker, 2005, Vaginal delivery of two cases of brow presentation using multiple Kiwi Omnicups, J Obstet Gynaecol, 25, 601, 10.1080\u002F01443610500242309\nHakmi, 2008, Brow presentation does not mean caesarean section, J Obstet Gynaecol, 28, 255, 10.1080\u002F01443610801976050\nGernez, 1978, La présentation du bregma, cette méconnue, Rev Fr Gynecol Obstet, 73, 757\nThoulon JM, Welfen-Ekra C, Arnould P, Audra P. Étude anatomoclinique et radiologique du bassin obstétrical. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-007-A-10, 1997.",{"ES":1375},"Presentaciones en extensión",{"VOID":1377},"10.1016\u002Fs1283-081x(20)43356-9","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20433569",[1380,1395,1410,1422,1434],{"id":1381,"sortIndex":36,"researcher":26,"roles":1382,"affiliations":1383,"properties":1392},"52b241a3-05f1-4e9f-b327-9576935c6f7f",[696],[1384],{"id":26,"sortIndex":36,"affiliation":1385,"properties":26},{"id":1386,"createTime":1387,"updateTime":1387,"relativeEntities":1388,"slug":26,"properties":1389,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6272e170-9888-4f00-8df9-3ed420a10323","2024-01-16T22:01:37.100+00:00",[],{"title":1390},{"VI":1391},"Service de gynécologie-obstétrique, CHU de Grenoble-Alpes, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France",{"title":1393},{"VI":1394},"D. Riethmuller",{"id":1396,"sortIndex":114,"researcher":26,"roles":1397,"affiliations":1398,"properties":1407},"404b4d19-6964-41b3-95b0-d366e21d1f3a",[696],[1399],{"id":26,"sortIndex":36,"affiliation":1400,"properties":26},{"id":1401,"createTime":1402,"updateTime":1402,"relativeEntities":1403,"slug":26,"properties":1404,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b408642c-87d7-462f-8f83-9992d6839849","2024-01-16T22:01:37.142+00:00",[],{"title":1405},{"VI":1406},"Pôle Mère-Femme, CHU de Besançon, Besançon, France",{"title":1408},{"VI":1409},"R. Ramanah",{"id":1411,"sortIndex":111,"researcher":26,"roles":1412,"affiliations":1413,"properties":1419},"3ce2cfb4-2d19-4ffa-b07b-2956c4d99f99",[696],[1414],{"id":26,"sortIndex":36,"affiliation":1415,"properties":26},{"id":1386,"createTime":1387,"updateTime":1387,"relativeEntities":1416,"slug":26,"properties":1417,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1418},{"VI":1391},{"title":1420},{"VI":1421},"V. Equy",{"id":1423,"sortIndex":59,"researcher":26,"roles":1424,"affiliations":1425,"properties":1431},"ecd3b28a-08e8-4bc3-95ca-40ff9c4eacb7",[696],[1426],{"id":26,"sortIndex":36,"affiliation":1427,"properties":26},{"id":1401,"createTime":1402,"updateTime":1402,"relativeEntities":1428,"slug":26,"properties":1429,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1430},{"VI":1406},{"title":1432},{"VI":1433},"L. Courtois",{"id":1435,"sortIndex":115,"researcher":26,"roles":1436,"affiliations":1437,"properties":1443},"8cb19c6a-9336-4882-a326-5e4431f596c9",[696],[1438],{"id":26,"sortIndex":36,"affiliation":1439,"properties":26},{"id":1401,"createTime":1402,"updateTime":1402,"relativeEntities":1440,"slug":26,"properties":1441,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1442},{"VI":1406},{"title":1444},{"VI":1445},"N. Mottet",{"url":1378,"publisher":1447,"properties":1455},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1448,"slug":662,"properties":1449,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1452,"manageAffiliations":1453,"indexDatabases":1454,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1450,"title":1451},{"VOID":665},{"EN":667},[],[],[],{"volume":1456,"pages":1457},{"VOID":759},{"VOID":1288},"2020-03-01",{"id":1460,"createTime":1461,"updateTime":1462,"relativeEntities":1463,"slug":1464,"properties":1465,"entityType":688,"verifyStatus":25,"verifyTime":1462,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1472,"fullTextUrl":26,"authors":1473,"publicationType":747,"publisherRelationship":1531,"citationCount":26,"citationInfo":26,"publishDate":1544,"publishYear":1545,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"6295d359-68af-4766-aaf7-4883bc9227ad","2023-12-28T21:25:20.387+00:00","2025-02-09T18:50:52.785+00:00",[],"C%C3%A1ncer-de-endometrio",{"references":1466,"title":1468,"doi":1470},{"VOID":1467},"Jemal, 2005, Cancer statistics, 2005, CA Cancer J. Clin., 55, 10, 10.3322\u002Fcanjclin.55.1.10\nMadison, 2004, Endometrial cancer: socioeconomic status and racial\u002Fethnic differences in stage at diagnosis, treatment, and survival, Am. J. Public Health, 94, 2104, 10.2105\u002FAJPH.94.12.2104\nGershenson, 2004\nCalle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults, N. Engl. J. Med., 348, 1625, 10.1056\u002FNEJMoa021423\nSwanson, 1993, Relation of endometrial cancer risk to past and contemporary body size and body fat distribution, Cancer Epidemiol. Biomarkers Prev., 2, 321\nPotischman, 1996, Case-control study of endogenoussteroid hormones and endometrial cancer, J. Natl. Cancer Inst., 88, 1127, 10.1093\u002Fjnci\u002F88.16.1127\nRichelson, 1984, Relative contributions of aging and estrogen deficiency to post-menopausal bone loss, N. Engl. J. Med., 311, 1273, 10.1056\u002FNEJM198411153112002\nKlip, 2000, Cancer risk associated with subfertility and ovulation induction: a review, Cancer Causes Control, 11, 319, 10.1023\u002FA:1008921211309\nLambe, 1999, Childbearing at older age and endometrial cancer risk, Cancer Causes Control, 10, 43, 10.1023\u002FA:1008860615584\nPetrakis, 1987, Influence of pregnancy and lactation on serum and breast fluid estrogen level: implications for breast cancer risk, Int. J. Cancer, 40, 587, 10.1002\u002Fijc.2910400502\nSalerno, 1962, Feminizing mesenchymomas of the ovary: an analysis of 28 granulosa-theca cell tumors and their relationshipto co-existent carcinoma, Am. J. Obstet. Gynecol., 84, 731, 10.1016\u002F0002-9378(62)90022-4\nSpeert, 1949, Endometrial cancer and hepatic cirrhosis, Cancer, 2, 597, 10.1002\u002F1097-0142(194907)2:4\u003C597::AID-CNCR2820020407>3.0.CO;2-0\nDeligeoroglou, 2003, Oral contraceptives and reproductive system cancer, Ann. N. Y. Acad. Sci., 997, 199, 10.1196\u002Fannals.1290.023\n1983, Oral contraceptive use and the risk of endometrial cancer, JAMA, 249, 1600, 10.1001\u002Fjama.1983.03330360040033\nWeiderpass, 1999, Use of oral contraceptives and endometrial cancer risk (Sweden), Cancer Causes Control, 10, 277, 10.1023\u002FA:1008945721786\nLawrence, 1987, Smoking, body weight, and early-stage endometrial cancer, Cancer, 59, 1665, 10.1002\u002F1097-0142(19870501)59:9\u003C1665::AID-CNCR2820590924>3.0.CO;2-2\nHemminki, 2004, Familial clustering of ovarian and endometrial cancers, Eur. J. Cancer, 40, 90, 10.1016\u002FS0959-8049(03)00627-0\nUmar, 2004, Testing guidelines for hereditary non-polyposis colorectal cancer, Nat. Rev. Cancer, 4, 153, 10.1038\u002Fnrc1278\nGehrig, 2004, Association between uterine serous carcinoma and breast cancer, Gynecol. Oncol., 94, 208, 10.1016\u002Fj.ygyno.2004.04.009\nLanger, 1997, Transvaginal ultrasonography comprared with endometrial biopsy for the detection of endometrial disease\u002F Post menopausal estrogen\u002Fprogestin interventions trial, N. Engl. J. Med., 337, 1792, 10.1056\u002FNEJM199712183372502\nRobertson, 2003, Screening for endometrial cancer, Med. J. Aust., 178, 657, 10.5694\u002Fj.1326-5377.2003.tb05400.x\nGerber, 2001, Ultrasonographic detection of asymptomatic endometrial cancer in post menopausal patients offers no pronostic advantage over symptomatic disease discovered by uterine bleeding, Eur. J. Cancer, 37, 64, 10.1016\u002FS0959-8049(00)00356-7\nKim, 1998, Diagnostic and therapeutic advances in gynecology oncology: screening for gynecologic cancer, Cancer Treat. Res., 95, 253, 10.1007\u002F978-1-4615-5447-9_9\nLhomme, 2003, Endometrial surveillance of women on tamoxifen, Gynecol. Obstet. Fertil., 31, 647\nNeven, 1998, Should tamoxifen users be screened for endometrial lesions?, Lancet, 351, 155, 10.1016\u002FS0140-6736(05)78216-7\nLu, 2005, Gynecologic cancer as a \"sentinel cancer\" for women with hereditary non polyposis colorectal cancer syndrome, Obstet. Gynecol., 105, 569, 10.1097\u002F01.AOG.0000154885.44002.ae\nStefansson, 2004, Pronostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type, Histopathology, 44, 472, 10.1111\u002Fj.1365-2559.2004.01882.x\nLax, 2000, A binary architectural grading system for uterine endometrioid carcinoma has superior reproductibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis, Am. J. Surg. Pathol., 24, 1201, 10.1097\u002F00000478-200009000-00002\nZaino, 1988, Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma, Semin. Diagn. Pathol., 5, 154\nSlomovitz, 2003, Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases, Gynecol. Oncol., 91, 463, 10.1016\u002Fj.ygyno.2003.08.018\nWheeler, 2000, Minimal uterine serous carcinoma diagnosis and clinicopathologic correlation, Am. J. Surg. Pathol., 24, 797, 10.1097\u002F00000478-200006000-00004\nGoff, 2005, Uterine papillary serous carcinoma: what have we learned over the past quarter century?, Gynecol. Oncol., 98, 341, 10.1016\u002Fj.ygyno.2005.07.006\nSherman, 1992, Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features, Am. J. Surg. Pathol., 16, 600, 10.1097\u002F00000478-199206000-00008\nAmant, 2005, Endometrial cancer, Lancet, 366, 491, 10.1016\u002FS0140-6736(05)67063-8\nAmbros, 1995, Endometrial intraepithelial carcinoma: a distinctive lesion speciffically associated with tumors displaying serous differentiation, Hum. Pathol., 26, 1260, 10.1016\u002F0046-8177(95)90203-1\nCarcangiu, 1997, Stage IA uterine serous carcinoma: a study of 13 cases, Am. J. Surg. Pathol., 21, 1507, 10.1097\u002F00000478-199712000-00015\nSoslow, 2000, Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis, Am. J. Surg. Pathol., 24, 726, 10.1097\u002F00000478-200005000-00012\nEifel, 1982, Simultaneous presentation of carcinoma involving the ovary and the uterine corpus, Cancer, 50, 163, 10.1002\u002F1097-0142(19820701)50:1\u003C163::AID-CNCR2820500131>3.0.CO;2-K\nBrinkmann, 2004, A molecular genetic and statistical approach for the diagnosisof dual-site cancers, J. Natl. Cancer Inst., 96, 1441, 10.1093\u002Fjnci\u002Fdjh272\nBokhman, 1983, Two pathogenetic types of endometrial carcinoma, Gynecol. Oncol., 15, 10, 10.1016\u002F0090-8258(83)90111-7\nGupta, 2002, Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis, Acta Obstet. Gynecol. Scand., 81, 799, 10.1034\u002Fj.1600-0412.2001.810902.x\nSmith-Bindman, 1998, Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities, JAMA, 280, 1510, 10.1001\u002Fjama.280.17.1510\nTabor, 2002, Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding, Obstet. Gynecol., 99, 663\nTrimble, 2005, Atypical endometrial hyperplasia: a tough call, Int. J. Gynecol. Cancer, 15, 401, 10.1111\u002Fj.1525-1438.2005.t01-1-abst_5.x\nEddy, 1997, Papanicolaou smears by the Bethesda system in endometrial malignancy: utility and pronostic importance, Obstet. Gynecol., 90, 999, 10.1016\u002FS0029-7844(97)00548-6\nFukuda, 1999, Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance, Gynecol. Oncol., 72, 273, 10.1006\u002Fgyno.1998.5244\nLarson, 1994, Pronostic significance of malignant cervical cytology in patient with endometrial cancer, Obstet. Gynecol., 84, 399\nGoff, 1994, Surgical stage IV endometrial carcinoma: a study of 47 cases, Gynecol. Oncol., 52, 237, 10.1006\u002Fgyno.1994.1038\nHricak, 1987, Endometrial carcinoma staging by MR imaging, Radiology, 162, 297, 10.1148\u002Fradiology.162.2.3797641\nDubinsky, 1997, The role of transvaginal sonography and endometrial biopsy in the evaluation of peri and postmenopausal bleeding, Am. J. Roentgenol., 169, 145, 10.2214\u002Fajr.169.1.9207515\nGoldstein, 2001, Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Concensus Conference statement, J. Ultrasound. Med., 20, 1025, 10.7863\u002Fjum.2001.20.10.1025\nGull, 2003, Can ultrasound replace dilatation and curettag? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer, Am. J. Obstet. Gynecol., 188, 401, 10.1067\u002Fmob.2003.154\nGrasel, 2000, Endometrial polyps: MR imaging features and distinction from endometrial carcinoma, Radiology, 214, 47, 10.1148\u002Fradiology.214.1.r00ja3647\nWeber, 1997, Vaginal ultrasonography versus endometrial biopsy in women with postmenopausal bleeding, Am. J. Obstet. Gynecol., 177, 924, 10.1016\u002FS0002-9378(97)70295-3\nFerrazzi, 1996, Sonographic endometrial thickness: a useful test to predict atrophy in patients with post menopausal bleeding. An italian multicenter study, Ultrasound Obstet. Gynecol., 7, 315, 10.1046\u002Fj.1469-0705.1996.07050315.x\nDijkhuizen, 2000, The accuracy of endometrial sampling in the diagnosis of patients with endometrial cancer: a systematic quantitative review, Cancer, 89, 1765, 10.1002\u002F1097-0142(20001015)89:8\u003C1765::AID-CNCR17>3.0.CO;2-F\nKarlsson, 1995, Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: A Nordic Multicenter Study, Am. J. Obstet. Gynecol., 172, 1488, 10.1016\u002F0002-9378(95)90483-2\nPhillip, 2004, Correlation between transvaginal ultrasound measured endometrial thickness and histopathologic findings in Afro-Carrbean Jamaican women with postmenopausal bleeding, J. Obstet. Gynecol., 24, 568, 10.1080\u002F01443610410001722671\nvan Doorn, 2004, Accuracy of transvaginal ultrasonography in diabetic or obese women with post menopausal bleeding, Obstet. Gynecol., 104, 571, 10.1097\u002F01.AOG.0000136080.55874.7f\nWang, 2006, Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers, Gynecol. Oncol., 101, 120, 10.1016\u002Fj.ygyno.2005.09.042\nSchwarzler, 1998, An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology, Ultrasound Obstet. Gynecol., 11, 337, 10.1046\u002Fj.1469-0705.1998.11050337.x\nGoldstein, 1997, Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding, Am. J. Obstet. Gynecol., 177, 102, 10.1016\u002FS0002-9378(97)70446-0\nAyhan, 1994, Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases), Int. J. Gynecol. Cancer, 4, 306, 10.1046\u002Fj.1525-1438.1994.04050306.x\nBradley, 2004, Hysteroscopy and cytology in endometrial cancer, Obstet. Gynecol., 104, 1030, 10.1097\u002F01.AOG.0000143263.19732.18\nNarducci, 2006, What is new in the surgical treatment of pelvic gynecologic cancers?, Bull. Cancer, 93, 43\nDessole, 2006, Risks and usefulness of sonohysterography in patients with endometrial carcinoma, Am. J. Obstet. Gynecol., 194, 362, 10.1016\u002Fj.ajog.2005.08.036\nValenzano, 2001, The role of transvaginal ultrasound and sonohysterography in the diagnosis and staging of endometrial adenocarcinoma, Radiol. Med. (Torino), 101, 365\nClark, 2002, Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review, BJOG, 109, 313, 10.1111\u002Fj.1471-0528.2002.01088.x\nKoss, 1981, Screening of asymptomatic women for endometrial cancer, Obstet. Gynecol., 57, 681\nGarcia, 2003, Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding, J. Reprod. Med., 48, 882\nEpstein, 2001, Dilatation and curettage fails to detect most focal lésions in the uterine cavity in women with post menopausal bleeding, Acta Obstet. Gynecol. Scand., 80, 1121, 10.1034\u002Fj.1600-0412.2001.801210.x\nObermair, 1999, Endometrial cancer accuracy of the finding of a well-differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy, Int. J. Gynecol. Cancer, 9, 383, 10.1046\u002Fj.1525-1438.1999.99050.x\nDaniel, 1988, Accuracy of office and operating room curretage in the grading of endometrial carcininoma, Obstet. Gynecol., 71, 612\nDijkhuizen, 2003, Cost-effectiveness of the use of transvaginal sonography in the evaluation of post menopausal bleeding, Maturitas, 45, 275, 10.1016\u002FS0378-5122(03)00152-X\nClark, 2006, Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies, BJOG, 113, 502, 10.1111\u002Fj.1471-0528.2006.00914.x\nCreasman, 1989, FIGO stage 1988 revision, Gynecol. Oncol., 35, 125\nCreutzberg, 2000, Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma, Lancet, 355, 1404, 10.1016\u002FS0140-6736(00)02139-5\nZuurendonk, 2006, Routine pelvic lymphadenectomy in apparently early stage endometrial cancer, Eur. J. Surg. Oncol., 32, 450, 10.1016\u002Fj.ejso.2006.02.008\nKinkel, 1999, Radiologic staging in patients with endometrial cancer: a meta-analysis, Radiology, 212, 711, 10.1148\u002Fradiology.212.3.r99au29711\nBoronow, 1984, Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study, Obstet. Gynecol., 63, 825\nCreasman, 1987, Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study, Cancer, 60, 2035, 10.1002\u002F1097-0142(19901015)60:8+\u003C2035::AID-CNCR2820601515>3.0.CO;2-8\nPiver, 1982, Paraaortic lymph node evaluation in stage I endometrial carcinoma, Obstet. Gynecol., 59, 97\nSironi, 1992, Myometrialinvasion by endometrial carcinoma: assessment with plain and galodinium-enhanced MR imaging, Radiology, 185, 207, 10.1148\u002Fradiology.185.1.1523309\nGoff, 1990, Assessment of depth of myometrial invasion in endometrial adenocarcinoma, Gynecol. Oncol., 38, 46, 10.1016\u002F0090-8258(90)90009-A\nDoering, 1989, Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma, Obstet. Gynecol., 74, 930\nQuinlivan, 2001, Accuracy of frozen section for the operative management of endometrial cancer, BJOG, 108, 798\nFrumovitz, 2004, Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer, J. Am. Coll. Surg., 199, 388, 10.1016\u002Fj.jamcollsurg.2004.05.258\nOlaya, 1998, Transvaginal sonography in endometrial carcinoma: preoperative assessment of the depth of myometrial invasion in 50 cases, Eur. J. Radiol., 26, 274, 10.1016\u002FS0720-048X(96)01129-1\nTeefey, 1996, Local staging of endometrial carcinoma:comparison of transvaginal and intraoperative sonography and gross visual inspection, AJR Am. J. Roentgenol., 166, 547, 10.2214\u002Fajr.166.3.8623626\nYamashita, 1993, Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging, AJR Am. J. Roentgenol., 161, 595, 10.2214\u002Fajr.161.3.8352114\nBalfe, 1983, Computed tomography in malignant endometrial neoplasms, J. Comput. Assist. Tomogr., 7, 677, 10.1097\u002F00004728-198308000-00018\nDore, 1987, CT evaluation of myometrium invasion in endometrial carcinoma, J. Comput. Assist. Tomogr., 11, 282, 10.1097\u002F00004728-198703000-00018\nKim, 1995, Detection of deep myometrial invasion in endometrial carcinoma:comparison of transvaginal ultrasound, CT, and MRI, J. Comput. Assist. Tomogr., 19, 766, 10.1097\u002F00004728-199509000-00013\nWalsh, 1982, Computed tomography of primary persistent, and recurrent endometrial malignancy, Am. J. Roentgenol., 139, 1149, 10.2214\u002Fajr.139.6.1149\nConnor, 2000, Computed tomography in endometrial carcinoma, Obstet. Gynecol., 95, 692\nJoja, 1996, Endometrial carcinoma: dynamic MRI with turbo-FLASH technique, J. Comput. Assist. Tomogr., 20, 878, 10.1097\u002F00004728-199611000-00003\nManfredi, 2005, Endometrial cancer: magnetic resonance imaging, Abdom. Imaging, 30, 626, 10.1007\u002Fs00261-004-0298-9\nSavci, 1998, Assessment of depth of myometrial carcinoma:comparison of T2-weighted SE and contrast-enhanced dynamic GRE MR imaging, Eur. Radiol., 8, 218, 10.1007\u002Fs003300050365\nIto, 2004, Endometrial cancer diagnosis by MR imaging, Nippon Rinsho, 62, 313\nSeki, 2000, Value of dynamic MR imaging in assessing endometrial carcinoma involvement of the cervix, Am. J. Roentgenol., 175, 171, 10.2214\u002Fajr.175.1.1750171\nToki, 1998, A comparative study of pre-operative procedures to assess cervical invasion by endometril carcinoma, Br. J. Obstet. Gynaecol., 105, 512, 10.1111\u002Fj.1471-0528.1998.tb10151.x\nBurghardt, 1978, Local spread and lymph node involvement in cervical cancer, Obstet. Gynecol., 52, 138\nTrattner, 2001, Prognostic factors in surgically treated stage Ib-IIb cervical carcinomas with special emphasis on the importance of tumor volume, Gynecol. Oncol., 82, 11, 10.1006\u002Fgyno.2001.6252\nMeroni, 2004, T2 weighted MRI in the pre-operative assessment of myometrial and cervical invasions in endometrial carcinoma, Br J Radiol Congress Series, 30, 6\nO'Connel, 1998, Triage of abnormal postmenopausal bleeding: a comparaison of endometrial biopsy and transvaginal sonohysterography versus fractional curettage with hysteroscopy, Am. J. Obstet. Gynecol., 178, 956, 10.1016\u002FS0002-9378(98)70530-7\nKim, 1994, Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging, Radiology, 190, 807, 10.1148\u002Fradiology.190.3.8115631\nBipat, 2003, Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review, Gynecol. Oncol., 91, 59, 10.1016\u002FS0090-8258(03)00409-8\nRockall, 2005, Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer, J. Clin. Oncol., 23, 2813, 10.1200\u002FJCO.2005.07.166\nManfredi, 2004, Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning, Radiology, 231, 372, 10.1148\u002Fradiol.2312021184\nAscher, 2002, Imaging of cancer of the endometrium, Radiol. Clin. North Am., 40, 563, 10.1016\u002FS0033-8389(01)00013-6\nBerman, 1980, Prognosis and treatment of endometrial cancer, Am. J. Obstet. Gynecol., 136, 679, 10.1016\u002F0002-9378(80)91024-8\nChao, 2006, 18F-FDG PET in the management of endometrial cancer, Eur. J. Nucl. Med. Mol. Imaging, 33, 36, 10.1007\u002Fs00259-005-1876-y\nHorowitz, 2004, Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer, Gynecol. Oncol., 95, 546, 10.1016\u002Fj.ygyno.2004.08.009\nSood, 1997, Value of preoperative CA125 level in the management of uterine cancer and prediction of clinical outcome, Obstet. Gynecol., 90, 441, 10.1016\u002FS0029-7844(97)00286-X\nDotters, 2000, Preoperative CA125 in endometrial cancer: is it useful?, Am. J. Obstet. Gynecol., 182, 1328, 10.1067\u002Fmob.2000.106251\nMorrow, 1991, Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study, Gynecol. Oncol., 40, 55, 10.1016\u002F0090-8258(91)90086-K\nCreasman, 1981, Pronostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals, Am. J. Obstet. Gynecol., 141, 921, 10.1016\u002FS0002-9378(16)32684-9\nSaga, 2006, Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?, Gynecol. Oncol., 103, 277, 10.1016\u002Fj.ygyno.2006.03.003\nTurner, 1989, The pronostic significance of peritonel cytology for stage I endometrial cancer, Obstet. Gynecol., 74, 775\nObermair, 2000, Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioïd adenocarcinoma of the uterus, Cancer Lett., 164, 105, 10.1016\u002FS0304-3835(00)00722-9\nKasamatsu, 2003, Pronostic significance of peritoneal cytology in endometrial carcinoma confined to the uterus, Br. J. Cancer, 88, 245, 10.1038\u002Fsj.bjc.6600698\nTebeu, 2004, Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis, Br. J. Cancer, 91, 720, 10.1038\u002Fsj.bjc.6602035",{"ES":1469},"Cáncer de endometrio",{"VOID":1471},"10.1016\u002Fs1283-081x(09)70794-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X09707945",[1474,1489,1504,1519],{"id":1475,"sortIndex":59,"researcher":26,"roles":1476,"affiliations":1477,"properties":1486},"cef910cc-fa95-4bae-8172-8046433edf2f",[696],[1478],{"id":26,"sortIndex":36,"affiliation":1479,"properties":26},{"id":1480,"createTime":1481,"updateTime":1481,"relativeEntities":1482,"slug":26,"properties":1483,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"790aef77-2587-4290-96a5-b3728d6154d7","2023-12-28T21:25:20.452+00:00",[],{"title":1484},{"VI":1485},"Service d'anatomie pathologique, Hôpital Jeanne de Flandre, Centre hospitalier régional universitaire de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France",{"title":1487},{"VI":1488},"M.-O. Farine",{"id":1490,"sortIndex":114,"researcher":26,"roles":1491,"affiliations":1492,"properties":1501},"d31b973b-ee99-47cf-ae97-31689369e959",[696],[1493],{"id":26,"sortIndex":36,"affiliation":1494,"properties":26},{"id":1495,"createTime":1496,"updateTime":1496,"relativeEntities":1497,"slug":26,"properties":1498,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"cecee8a2-37a4-4d94-9091-7ab927f86a9f","2023-12-28T21:25:20.437+00:00",[],{"title":1499},{"VI":1500},"Service de radiologie, Hôpital Jeanne de Flandre, Centre hospitalier régional universitaire de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France",{"title":1502},{"VI":1503},"E. Poncelet",{"id":1505,"sortIndex":115,"researcher":26,"roles":1506,"affiliations":1507,"properties":1516},"84006b33-c306-4c93-9b75-ac620154bf45",[696],[1508],{"id":26,"sortIndex":36,"affiliation":1509,"properties":26},{"id":1510,"createTime":1511,"updateTime":1511,"relativeEntities":1512,"slug":26,"properties":1513,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6c25f16e-a544-4f68-9f28-7f0cc22dbc6a","2023-12-28T21:25:20.402+00:00",[],{"title":1514},{"VI":1515},"Service de chirurgie gynécologique, Hôpital Jeanne de Flandre, Centre hospitalier régional universitaire de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France",{"title":1517},{"VI":1518},"P. Collinet",{"id":1520,"sortIndex":36,"researcher":26,"roles":1521,"affiliations":1522,"properties":1528},"4789b1fe-417d-4eb8-a059-6833ff9b4245",[696],[1523],{"id":26,"sortIndex":36,"affiliation":1524,"properties":26},{"id":1510,"createTime":1511,"updateTime":1511,"relativeEntities":1525,"slug":26,"properties":1526,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1527},{"VI":1515},{"title":1529},{"VI":1530},"D. Vinatier",{"url":1472,"publisher":1532,"properties":1540},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1533,"slug":662,"properties":1534,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1537,"manageAffiliations":1538,"indexDatabases":1539,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1535,"title":1536},{"VOID":665},{"EN":667},[],[],[],{"volume":1541,"pages":1543},{"VOID":1542},"45",{"VOID":1288},"2009-01-01",2009,{"id":1547,"createTime":1548,"updateTime":1549,"relativeEntities":1550,"slug":1551,"properties":1552,"entityType":688,"verifyStatus":25,"verifyTime":1549,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1559,"fullTextUrl":26,"authors":1560,"publicationType":747,"publisherRelationship":1600,"citationCount":26,"citationInfo":26,"publishDate":1614,"publishYear":1615,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"b01aff45-1715-4944-8358-bf5ecf6e69ef","2024-01-12T04:08:28.664+00:00","2024-12-05T23:50:18.874+00:00",[],"Recidiva-locorregional-del-c%C3%A1ncer-de-mama",{"references":1553,"title":1555,"doi":1557},{"VOID":1554},"Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantony E, et al. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. 2019. https:\u002F\u002Fwww.santepubliquefrance.fr\u002Fmaladies-et-traumatismes\u002Fcancers\u002Fcancer-du-sein\u002Fdocuments\u002Frapport-synthese\u002Festimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaineentre-1990-et-2018-volume-1-tumeurs-solides-etud.\nAnderson, 2009, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer, J Clin Oncol, 27, 2466, 10.1200\u002FJCO.2008.19.8424\nAndry, 1989, Locoregional recurrences after 649 modified radical mastectomies: incidence and significance, Eur J Surg Oncol, 15, 476\nArriagada, 2002, Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer, Ann Oncol, 13, 1404, 10.1093\u002Fannonc\u002Fmdf227\nClemons, 2001, Locoregionally recurrent breast cancer: incidence, risk factors and survival, Cancer Treat Rev, 27, 67, 10.1053\u002Fctrv.2000.0204\nFortin, 1999, Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy, J Clin Oncol, 17, 101, 10.1200\u002FJCO.1999.17.1.101\nSchmoor, 2000, Role of isolated locoregional recurrence of breast cancer: results of four prospective studies, J Clin Oncol, 18, 1696, 10.1200\u002FJCO.2000.18.8.1696\nWapnir, 2006, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials, J Clin Oncol, 24, 2028, 10.1200\u002FJCO.2005.04.3273\nTaghian, 2004, J Clin Oncol, 22, 4247, 10.1200\u002FJCO.2004.01.042\nFisher, 1991, Significance of ipsilateral breast tumour recurrence after lumpectomy, Lancet, 338, 327, 10.1016\u002F0140-6736(91)90475-5\nFisher, 1992, Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06, Semin Surg Oncol, 8, 161\nVeronesi, 1995, Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events, J Natl Cancer Inst, 87, 19, 10.1093\u002Fjnci\u002F87.1.19\nFisher, 2002, Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer, N Engl J Med, 347, 1233, 10.1056\u002FNEJMoa022152\nGalper, 2005, Prognosis after local recurrence after conservative surgery and radiation for earlystage breast cancer, Int J Radiat Oncol Biol Phys, 61, 348, 10.1016\u002Fj.ijrobp.2004.06.011\nLe, 2002, Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma, Cancer, 94, 2813, 10.1002\u002Fcncr.10572\nSalvadori, 1999, Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery, Br J Surg, 86, 84, 10.1046\u002Fj.1365-2168.1999.00961.x\nClarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016\u002FS0140-6736(05)67887-7\nBlichert-Toft, 1992, Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group, J Natl Cancer Inst Monogr, 19\nJacobson, 1995, Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer, N Engl J Med, 332, 907, 10.1056\u002FNEJM199504063321402\nSarrazin, 1989, Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer, Radiother Oncol, 14, 177, 10.1016\u002F0167-8140(89)90165-5\nvan Dongen, 2000, Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial, J Natl Cancer Inst, 92, 1143, 10.1093\u002Fjnci\u002F92.14.1143\nVeronesi, 2002, Twenty-year follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, 1227, 10.1056\u002FNEJMoa020989\nMannino, 2009, Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?, Radiotherapy and Oncology, 90, 14, 10.1016\u002Fj.radonc.2008.05.002\nHuang, 2002, Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences, Cancer, 95, 2059, 10.1002\u002Fcncr.10952\nKomoike, 2005, Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors, Breast Cancer, 12, 104, 10.2325\u002Fjbcs.12.104\nPanet-Raymond, 2011, True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy, Int J Radiat Oncol Biol Phys, 81, 409, 10.1016\u002Fj.ijrobp.2010.05.063\nYi, 2011, Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning, Ann Surg, 253, 572, 10.1097\u002FSLA.0b013e318208fc2a\nYoshida, 2010, True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment, Breast J, 16, 127, 10.1111\u002Fj.1524-4741.2009.00884.x\nBollet, 2008, High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers, J Natl Cancer Inst, 100, 48, 10.1093\u002Fjnci\u002Fdjm266\nVicini, 2007, The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy, Cancer, 109, 1264, 10.1002\u002Fcncr.22529\nSmith, 2000, True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management, Int J Radiat Oncol Biol Phys, 48, 1281, 10.1016\u002FS0360-3016(00)01378-X\nWoodward, 2010, Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival, Breast Cancer Res Treat, 123, 597, 10.1007\u002Fs10549-010-0829-8\nBuchanan, 2006, Locoregional recurrence after mastectomy: incidence and outcomes, J Am Coll Surg, 203, 469, 10.1016\u002Fj.jamcollsurg.2006.06.015\nWapnir, 2008, Progress on BIG 1-02\u002FIBCSG 27-02\u002FNSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer, Ann Surg Oncol, 15, 3227, 10.1245\u002Fs10434-008-0129-2\nHarris, 2003, Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy, Cancer, 98, 2144, 10.1002\u002Fcncr.11767\nReddy, 2010, Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and Doxorubicin-based chemotherapy for breast cancer, Int J Radiat Oncol Biol Phys, 80, 1453, 10.1016\u002Fj.ijrobp.2010.04.015\nJaffre, 2009, Prognosis for isolated skin recurrence after breast cancer treated by mastectomy, Anticancer Res, 29, 1697\nBurstein, 2004, Ductal carcinoma in situ of the breast, N Engl J Med, 350, 1430, 10.1056\u002FNEJMra031301\nBoyages, 1999, Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis, Cancer, 85, 616, 10.1002\u002F(SICI)1097-0142(19990201)85:3\u003C616::AID-CNCR12>3.0.CO;2-7\nWapnir, 2011, Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS, J Natl Cancer Inst, 103, 478, 10.1093\u002Fjnci\u002Fdjr027\nBijker, 2006, J Clin Oncol, 24, 3381, 10.1200\u002FJCO.2006.06.1366\nFisher, 2001, Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience, Semin Oncol, 28, 400, 10.1016\u002FS0093-7754(01)90133-2\nHolmberg, 2008, Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast, J Clin Oncol, 26, 1247, 10.1200\u002FJCO.2007.12.7969\nHoughton, 2003, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet, 362, 95\nViani, 2007, Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials, Radiat Oncol, 2, 28, 10.1186\u002F1748-717X-2-28\nSilverstein, 1999, The influence of margin width on local control of ductal carcinoma in situ of the breast, N Engl J Med, 340, 1455, 10.1056\u002FNEJM199905133401902\nSilverstein, 1996, A prognostic index for ductal carcinoma in situ of the breast, Cancer, 77, 2267, 10.1002\u002F(SICI)1097-0142(19960601)77:11\u003C2267::AID-CNCR13>3.0.CO;2-V\nWong, 2006, Prospective study of wide excision alone for ductal carcinoma in situ of the breast, J Clin Oncol, 24, 1031, 10.1200\u002FJCO.2005.02.9975\nHughes, 2009, Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group, J Clin Oncol, 27, 5319, 10.1200\u002FJCO.2009.21.8560\nMotwani, 2011, Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194, Cancer, 117, 1156, 10.1002\u002Fcncr.25623\nMeattini, 2017, Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: long-term experience from two large-institutional series, Breast, 33, 139, 10.1016\u002Fj.breast.2017.03.017\nTay, 2020, Impact of hormonal status on ductal carcinoma in situ of the breast: outcome and prognostic factors, Breast J, 26, 937, 10.1111\u002Ftbj.13738\nWu, 2020, Recurrence outcomes after nipple-sparing mastectomy and immediate breast reconstruction in patients with pure ductal carcinoma in situ, Ann Surg Oncol, 27, 1627, 10.1245\u002Fs10434-019-08184-z\nMarinovich, 2016, The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis, Ann Surg Oncol, 23, 3811, 10.1245\u002Fs10434-016-5446-2\nSigal-Zafrani, 2004, Histological margin assessment for breast ductal carcinoma in situ: precision and implications, Mod Pathol, 17, 81, 10.1038\u002Fmodpathol.3800019\nvan la Parra, 2019, Oncoplastic level 2 mammoplasty for large DCIS: 5-year results, Ann Surg Oncol, 26, 2459, 10.1245\u002Fs10434-019-07423-7\nKrag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, 881, 10.1016\u002FS1470-2045(07)70278-4\nVeronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056\u002FNEJMoa012782\nKrag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, 11, 927, 10.1016\u002FS1470-2045(10)70207-2\nNaik, 2004, The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a followup study of 4008 procedures, Ann Surg, 240, 462, 10.1097\u002F01.sla.0000137130.23530.19\nvan der Ploeg, 2008, Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature, Eur J Surg Oncol, 34, 1277, 10.1016\u002Fj.ejso.2008.01.034\nDel Bianco, 2008, Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial, Eur J Surg Oncol, 34, 508, 10.1016\u002Fj.ejso.2007.05.017\nFisher, 1981, The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast, Surg Gynecol Obstet, 152, 765\nGoyal, 2004, Predictors of non-sentinel lymph node metastasis in breast cancer patients, Eur J Cancer, 40, 1731, 10.1016\u002Fj.ejca.2004.04.006\nHwang, 2003, Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer, Ann Surg Oncol, 10, 248, 10.1245\u002FASO.2003.05.020\nNos, 2003, Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases, Br J Surg, 90, 1354, 10.1002\u002Fbjs.4325\nAlran, 2007, Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy, Ann Surg Oncol, 14, 2195, 10.1245\u002Fs10434-006-9331-2\nCoutant, 2009, Validation of the Tenon breast cancer score for predicting nonsentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study, Breast Cancer Res Treat, 113, 537, 10.1007\u002Fs10549-008-9967-7\nHouvenaeghel, 2009, A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis, Eur J Surg Oncol, 35, 690, 10.1016\u002Fj.ejso.2008.10.003\nKimberly, 2003, A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy, Ann Surg Oncol, 10, 1140, 10.1245\u002FASO.2003.03.015\nGrube, 2001, Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial, Semin Surg Oncol, 20, 230, 10.1002\u002Fssu.1038\nGiuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001\u002Fjama.2011.90\nGiuliano, 2017, Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial, JAMA, 318, 918, 10.1001\u002Fjama.2017.11470\nGalimberti, 2018, Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year followup of a randomised, controlled phase 3 trial, Lancet Oncol, 19, 1385, 10.1016\u002FS1470-2045(18)30380-2\nde Boniface, 2017, Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial, BMC Cancer, 17, 379, 10.1186\u002Fs12885-017-3361-y\nBeadle, 2009, Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach, Int J Radiat Oncol Biol Phys, 73, 734, 10.1016\u002Fj.ijrobp.2008.04.078\nTruong, 2009, Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy, Int J Radiat Oncol Biol Phys, 73, 357, 10.1016\u002Fj.ijrobp.2008.04.034\nVoogd, 2001, Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials, J Clin Oncol, 19, 1688, 10.1200\u002FJCO.2001.19.6.1688\nGentilini, 2007, When can a second conservative approach be considered for ipsilateral breast tumour recurrence?, Ann Oncol, 18, 468, 10.1093\u002Fannonc\u002Fmdl424\nOh, 2006, The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is ‘young’?, Int J Radiat Oncol Biol Phys, 65, 1345, 10.1016\u002Fj.ijrobp.2006.03.028\nGarg, 2007, Effect of postmastectomy radiotherapy in patients \u003C 35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy, Int J Radiat Oncol Biol Phys, 69, 1478, 10.1016\u002Fj.ijrobp.2007.05.029\nPark, 2009, High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer, Int J Radiat Oncol Biol Phys, 73, 75, 10.1016\u002Fj.ijrobp.2008.04.007\nEwertz, 2011, Effect of obesity on prognosis after early-stage breast cancer, J Clin Oncol, 29, 25, 10.1200\u002FJCO.2010.29.7614\nGabos, 2010, The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer, Breast Cancer Res Treat, 124, 187, 10.1007\u002Fs10549-010-1135-1\nLi, 2011, Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 chinese breast cancer cases, Ann Surg Oncol, 18, 2492, 10.1245\u002Fs10434-011-1626-2\nSinn, 1998, Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy, Eur J Cancer, 34, 646, 10.1016\u002FS0959-8049(97)10106-X\nHolland, 1990, The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast, J Clin Oncol, 8, 113, 10.1200\u002FJCO.1990.8.1.113\nAlbert, 2010, Estrogen\u002Fprogesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer, Int J Radiat Oncol Biol Phys, 77, 1296, 10.1016\u002Fj.ijrobp.2009.12.011\nPanoff, 2011, Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation, Breast Cancer Res Treat, 128, 899, 10.1007\u002Fs10549-011-1495-1\nVoduc, 2010, Breast cancer subtypes and the risk of local and regional relapse, J Clin Oncol, 28, 1684, 10.1200\u002FJCO.2009.24.9284\nMeyers, 2011, Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer, Ann Surg Oncol, 18, 2851, 10.1245\u002Fs10434-011-1665-8\nMontagna, 2012, Breast cancer subtypes and outcome after local and regional relapse, Ann Oncol, 23, 324, 10.1093\u002Fannonc\u002Fmdr129\nFreedman, 2009, Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation, Cancer, 115, 946, 10.1002\u002Fcncr.24094\nAlbert, 2011, Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer, Cancer, 117, 1595, 10.1002\u002Fcncr.25694\nWapnir, 2018, Efficacy of chemotherapy for ER-Negative and ER-Positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial, J Clin Oncol, 36, 1073, 10.1200\u002FJCO.2017.76.5719\nPan, 2017, 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years, N Engl J Med, 377, 1836, 10.1056\u002FNEJMoa1701830\nLowery, 2012, Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype, Breast Cancer Res Treat, 133, 831, 10.1007\u002Fs10549-011-1891-6\nZumsteg, 2013, Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer, Ann Surg Oncol, 20, 3469, 10.1245\u002Fs10434-013-3011-9\nChen, 2017, Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer, Adv Radiat Oncol, 2, 105, 10.1016\u002Fj.adro.2017.01.012\nWang, 2010, Triplenegative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy, Int J Radiat Oncol Biol Phys, 80, 1095, 10.1016\u002Fj.ijrobp.2010.03.038\nKwan, 2010, Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1-2pN0 disease?, Ann Oncol, 21, 988, 10.1093\u002Fannonc\u002Fmdp396\nMamounas, 2010, Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20, J Clin Oncol, 28, 1677, 10.1200\u002FJCO.2009.23.7610\nMamounas, 2017, 21-Gene recurrence score and locoregional recurrence in nodepositive\u002Fer-positive breast cancer treated with chemo-endocrine therapy, J Natl Cancer Inst, 109, 10.1093\u002Fjnci\u002Fdjw259\nTurashvili, 2017, 21-Gene recurrence score and locoregional recurrence in lymph nodenegative, estrogen receptor-positive breast cancer, Breast Cancer Res Treat, 166, 69, 10.1007\u002Fs10549-017-4381-7\nBidard, 2009, Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer, Ann Oncol, 20, 1836, 10.1093\u002Fannonc\u002Fmdp200\nHoussami, 2010, Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy, Eur J Cancer, 46, 3219, 10.1016\u002Fj.ejca.2010.07.043\nAziz, 2006, The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer, Breast J, 12, 331, 10.1111\u002Fj.1075-122X.2006.00271.x\nChagpar, 2004, Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique, Am J Surg, 188, 399, 10.1016\u002Fj.amjsurg.2004.06.020\nMoore, 2000, Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy, Ann Surg, 231, 877, 10.1097\u002F00000658-200006000-00012\nvan Deurzen, 2016, Predictors of surgical margin following breastconserving surgery: a large population-based cohort study, Ann Surg Oncol, 23, 627, 10.1245\u002Fs10434-016-5532-5\nPleijhuis, 2013, A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making, Breast, 22, 773, 10.1016\u002Fj.breast.2013.01.010\nHeil, 2012, Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study, Ann Surg Oncol, 19, 541, 10.1245\u002Fs10434-011-1947-1\nGagliato Dde, 2014, Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer, J Clin Oncol, 32, 735, 10.1200\u002FJCO.2013.49.7693\nHennigs, 2016, Do patients after reexcision due to involved or close margins have the same risk of local recurrence as those after one-step breast-conserving surgery?, Ann Surg Oncol, 23, 1831, 10.1245\u002Fs10434-015-5067-1\nHolland, 1985, Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery, Cancer, 56, 979, 10.1002\u002F1097-0142(19850901)56:5\u003C979::AID-CNCR2820560502>3.0.CO;2-N\nFitzgerald, 2016, Close and positive lumpectomy margins are associated with similar rates of residual disease with additional surgery, Ann Surg Oncol, 23, 4270, 10.1245\u002Fs10434-016-5490-y\nGarvey, 2015, Rates of residual disease with close but negative margins in breast cancer surgery, Breast, 24, 413, 10.1016\u002Fj.breast.2015.03.005\nDemirci, 2012, Breast conservation therapy: the influence of molecular subtype and margins, Int J Radiation Oncol Biol Physics, 83, 814, 10.1016\u002Fj.ijrobp.2011.09.001\nJones, 2009, Impact of pathological characteristics on local relapse after breastconserving therapy: a subgroup analysis of the EORTC boost versus no boost trial, J Clin Oncol, 27, 4939, 10.1200\u002FJCO.2008.21.5764\nHoussami, 2014, The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis, Ann Surg Oncol, 21, 717, 10.1245\u002Fs10434-014-3480-5\nMoran, 2014, Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer, J Clin Oncol, 32, 1507, 10.1200\u002FJCO.2013.53.3935\nVaidya, 2020, Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial, BMJ, 370\nCuzick, 2011, Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\u002FANZ DCIS trial, Lancet Oncol, 12, 21, 10.1016\u002FS1470-2045(10)70266-7\nPetrelli, 2011, Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials, Radiother Oncol, 100, 195, 10.1016\u002Fj.radonc.2011.02.005\nMauri, 2005, Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis, J Natl Cancer Inst, 97, 188, 10.1093\u002Fjnci\u002Fdji021\nBuzdar, 2005, Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer, J Clin Oncol, 23, 3676, 10.1200\u002FJCO.2005.07.032\nLiedtke, 2008, Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer, J Clin Oncol, 26, 1275, 10.1200\u002FJCO.2007.14.4147\nChen, 2004, Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience, J Clin Oncol, 22, 2303, 10.1200\u002FJCO.2004.09.062\nBroecker, 2017, Neoadjuvant therapy combined with oncoplastic reduction for high-stage breast cancer patients, Ann Plast Surg, 78, S258, 10.1097\u002FSAP.0000000000001062\nMazouni, 2013, The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy, Breast, 22, 1189, 10.1016\u002Fj.breast.2013.07.055\nAlpert, 2005, Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation, Int J Radiat Oncol Biol Phys, 63, 845, 10.1016\u002Fj.ijrobp.2005.02.035\nSchnitt, 1985, Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance, Int J Radiat Oncol Biol Phys, 11, 1277, 10.1016\u002F0360-3016(85)90242-1\nKurtz, 1991, Is breast conservation after local recurrence feasible?, Cancer, 27, 240\nVoogd, 1999, Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local recurrence after breast conservation (BORST), Eur J Cancer, 35, 1828, 10.1016\u002FS0959-8049(99)00220-8\nSellam, 2019, Local recurrence of breast cancer: salvage lumpectomy as an option for local treatment, Breast J, 25, 619, 10.1111\u002Ftbj.13290\nKuerer, 2004, Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation, Cancer, 100, 2269, 10.1002\u002Fcncr.20257\nDeutsch, 2002, Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation, Int J Radiat Oncol Biol Phys, 53, 687, 10.1016\u002FS0360-3016(02)02785-2\nChadha, 2008, The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer, Brachytherapy, 7, 22, 10.1016\u002Fj.brachy.2007.10.006\nHannoun-Levi, 2013, Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group, Radiother Oncol, 108, 226, 10.1016\u002Fj.radonc.2013.03.026\nHannoun-Levi, 2011, Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction, Brachytherapy, 10, 171, 10.1016\u002Fj.brachy.2010.05.004\nHannoun-Levi, 2004, Partial breast irradiation as second conservative treatment for local breast cancer recurrence, Int J Radiat Oncol Biol Phys, 60, 1385, 10.1016\u002Fj.ijrobp.2004.05.035\nResch, 2002, Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy. a second chance to preserve the breast1, Radiology, 225, 713, 10.1148\u002Fradiol.2253011913\nTrombetta, 2008, Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience, Brachytherapy, 7, 29, 10.1016\u002Fj.brachy.2007.12.001\nVavassori, 2020, High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study, J Contemp Brachytherapy, 12, 207, 10.5114\u002Fjcb.2020.96860\nKuo, 2008, Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence, Int J Radiat Oncol Biol Phys, 72, 1456, 10.1016\u002Fj.ijrobp.2008.03.042\nMaaskant-Braat, 2013, Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature, Breast Cancer Res Treat, 138, 13, 10.1007\u002Fs10549-013-2409-1\nVugts, 2015, Improving the success rate of repeat sentinel node biopsy in recurrent breast cancer, Ann Surg Oncol, 22, S529, 10.1245\u002Fs10434-015-4787-6\nVugts, 2015, Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer, Breast Cancer Res Treat, 153, 549, 10.1007\u002Fs10549-015-3571-4\nBeck, 1983, Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients, J Clin Oncol, 1, 400, 10.1200\u002FJCO.1983.1.6.400\nHalverson, 1992, Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy, Am J Clin Oncol, 15, 93, 10.1097\u002F00000421-199204000-00001\nJanjan, 1986, Management of locoregional recurrent breast cancer, Cancer, 58, 1552, 10.1002\u002F1097-0142(19861001)58:7\u003C1552::AID-CNCR2820580728>3.0.CO;2-W\nRauschecker, 2001, Systemic therapy for treating locoregional recurrence in women with breast cancer, Cochrane Database Syst Rev, CD002195\nWaeber, 2003, Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23\u002F82) comparing tamoxifen with observation, Ann Oncol, 14, 1215, 10.1093\u002Fannonc\u002Fmdg347",{"ES":1556},"Recidiva locorregional del cáncer de mama",{"VOID":1558},"10.1016\u002Fs1283-081x(22)46718-x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X2246718X",[1561,1576,1588],{"id":1562,"sortIndex":115,"researcher":26,"roles":1563,"affiliations":1564,"properties":1573},"5635d257-5426-4a90-918d-397a90d7f98a",[696],[1565],{"id":26,"sortIndex":36,"affiliation":1566,"properties":26},{"id":1567,"createTime":1568,"updateTime":1568,"relativeEntities":1569,"slug":26,"properties":1570,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a40fbfc9-f226-4942-b18d-08639538be21","2024-01-12T04:08:28.851+00:00",[],{"title":1571},{"VI":1572},"Département de chirurgie oncologique, ICM Val d’Aurelle, rue de la Croix-Verte, 34298 Montpellier, France",{"title":1574},{"VI":1575},"C. Taoum",{"id":1577,"sortIndex":36,"researcher":26,"roles":1578,"affiliations":1579,"properties":1585},"088b5668-ccf2-4ccc-9e1f-710a39ebbf98",[696],[1580],{"id":26,"sortIndex":36,"affiliation":1581,"properties":26},{"id":1567,"createTime":1568,"updateTime":1568,"relativeEntities":1582,"slug":26,"properties":1583,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1584},{"VI":1572},{"title":1586},{"VI":1587},"P.-E. Colombo",{"id":1589,"sortIndex":114,"researcher":26,"roles":1590,"affiliations":1591,"properties":1597},"997809e6-5134-4187-8c55-2df934ca2a6c",[696],[1592],{"id":26,"sortIndex":36,"affiliation":1593,"properties":26},{"id":1567,"createTime":1568,"updateTime":1568,"relativeEntities":1594,"slug":26,"properties":1595,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1596},{"VI":1572},{"title":1598},{"VI":1599},"P. Rouanet",{"url":1559,"publisher":1601,"properties":1609},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1602,"slug":662,"properties":1603,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1606,"manageAffiliations":1607,"indexDatabases":1608,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1604,"title":1605},{"VOID":665},{"EN":667},[],[],[],{"volume":1610,"pages":1612},{"VOID":1611},"58",{"VOID":1613},"1-20","2022-07-01",2022,{"id":1617,"createTime":1618,"updateTime":1619,"relativeEntities":1620,"slug":1621,"properties":1622,"entityType":688,"verifyStatus":25,"verifyTime":1619,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1629,"fullTextUrl":26,"authors":1630,"publicationType":747,"publisherRelationship":1672,"citationCount":26,"citationInfo":26,"publishDate":1685,"publishYear":1686,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"94c04831-af32-4087-b4ae-9e39daabfab9","2023-12-09T17:52:26.224+00:00","2025-02-25T22:13:06.055+00:00",[],"Tumores-del-ovario-y-embarazo",{"references":1623,"title":1625,"doi":1627},{"VOID":1624},"Hill, 1998, The role of ultrasonography in the detection and management of adnexal masses during the second and third trimester of pregnancy, Am. J. Obstet. Gynecol., 179, 703, 10.1016\u002FS0002-9378(98)70068-7\nAgarwal, 2003, Management and outcome of pregnancies complicated with adnexal masses, Arch. Gynecol. Obstet., 267, 148, 10.1007\u002Fs00404-001-0287-y\nSchemler, 2005, Adnexal masses in pregnancy: surgery compared with observation, Obstet. Gynecol., 105\nNelson, 1986, Cysts in pregnancy discovered by ultrasonography, J. Clin. Ultrasound, 14, 509, 10.1002\u002Fjcu.1870140703\nCreasman, 1971, Carcinoma of the ovary associated with pregnancy, Obstet. Gynecol., 38, 111\nWhitecar, 1999, Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management, Am. J. Obstet. Gynecol., 181, 19, 10.1016\u002FS0002-9378(99)70429-1\nAbbott, 1990, Pelvic pain: lessons from anatomy and physiology, J. Emerg. Med., 8, 441, 10.1016\u002F0736-4679(90)90173-S\nSassone, 1991, Transvaginal sonographic characterization of ovarian disease: evaluation of a new screening system to predict ovarian malignancy, Obstet. Gynecol., 78, 70\nUsui, 2000, A retrospective survey of clinical, pathologic and prognostic features of adnexal masses operated on during pregnancy, J. Obstet. Gynaecol. Res., 181, 19\nSherard, 2003, Adnexal masses and pregnancy: a 12 years experience, Am. J. Obstet. Gynecol., 189, 358, 10.1067\u002FS0002-9378(03)00731-2\nBromley, 1997, Adnexal masses during pregnancy: accuracy of sonographic diagnosis and outcome, J. Ultrasound Med., 16, 447, 10.7863\u002Fjum.1997.16.7.447\nCurtis, 1993, Magnetic resonance imaging to avoid laparotomy in pregnancy, Obstet. Gynecol., 82, 833\nBernhard, 1999, Predictors of persistence of adnexal mass in pregnancy, Obstet. Gynecol., 93, 585\nBouguizane, 2003, Les torsions des annexes de l'utérus, J. Gynecol. Obstet. Biol. Reprod. (Paris), 32, 535\n1998, Morice p, Louis-Sylvestre C, Chapron C, Dubuisson JB. Laparoscopy for adnexal torsion in pregnant women, J. Reprod. Med., 43, 160\nCristalli, 1991, Value of celioscopic surgical treatment of ovarian tumors at the beginning of pregnancy, J. Gynecol. Obstet. Biol. Reprod. (Paris), 20, 665\nSoriano, 1999, Laparoscopy versus laparotomy in the management of adnexal masses during pregnancy, Fertil. Steril., 71, 955, 10.1016\u002FS0015-0282(99)00064-3\nKort, 1993, The effect of non obstetric operation during pregnancy, Surg. Gynecol. Obstet., 177, 371\nBassil, 1999, Successful laparoscopic management of adnexal torsion during week 25 of a twin pregnancy, Hum. Reprod., 14, 855, 10.1093\u002Fhumrep\u002F14.3.855\nGoffinet, 2001, Kystes ovariens et grossesse, J. Gynecol. Obstet. Biol. Reprod. (Paris), 30, 100\nPicone, 2004, Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review, Gynecol. Oncol., 94, 600, 10.1016\u002Fj.ygyno.2004.05.030\nQuerleu, 2002\nReedy, 1995, Maternal and fetal effects of laparoscopic insufflation in the gravid baboon, J. Am. Assoc. Gynecol. Laparosc., 2, 399, 10.1016\u002FS1074-3804(05)80060-X\nHunter, 1995, Carbon dioxide pneumoperitoneum induces fetal acidosis in a pregnant ewe model, Surg. Endosc., 9, 272, 10.1007\u002FBF00187767\nCuret, 1996, Laparoscopy during pregnancy, Arch. Surg., 131, 546, 10.1001\u002Farchsurg.1996.01430170092017\nAmos, 1996, Laparoscopy surgery during pregnancy, Am. J. Surg., 171, 435, 10.1016\u002FS0002-9610(97)89626-2\nCruz, 1997, Intraabdominal carbon dioxide insufflation in the pregnant ewe. Uterine flood flow, intraaniotic pressure, and cardiopulmonary effects, Anesthesiology, 87, 1596\nBarnard, 1995, Fetal response to carbon dioxide pneumoperitoneum in the pregnant ewe, Obstet. Gynecol., 85, 669, 10.1016\u002F0029-7844(95)00023-K\nReedy, 1997, Laparoscopy during pregnancy: a study of five fetal outcome parameters with use of the Swedis Health Registry, Am. J. Obstet. Gynecol., 177, 673, 10.1016\u002FS0002-9378(97)70163-7\nBouguizane, 2004, Laparoscopic management of adnexal tumors after the first trimester of pregnancy, J. Gynecol. Obstet. Biol. Reprod. (Paris), 33, 319\nMathevet, 2003, Laparoscopic management of adnexal masses in pregnancy: a case series, Eur. J. Obstet. Gynecol. Reprod. Biol., 108, 217, 10.1016\u002FS0301-2115(02)00374-3\nYuen, 1997, Laparoscopic management of adnexal mass during pregnancy, Acta Obstet. Gynecol. Scand., 76, 173, 10.3109\u002F00016349709050076\nMoore, 1999, Laparoscopic management of adnexal massess in pregnant women, J. Reprod. Med., 44, 97\nPlatek, 1995, The management of a persistent adnexal mass in pregnancy, Am. J. Obstet. Gynecol., 173, 1236, 10.1016\u002F0002-9378(95)91361-0\nUeda, 1996, Ovarian tumors associated with pregnancy, Int. J. Gynaecol. Obstet., 55, 59, 10.1016\u002F0020-7292(96)02718-X\nAkira, 1999, Gasless laparoscopic ovarian cystectomy during pregnancy: comparison with laparotomy, Am. J. Obstet. Gynecol., 180, 554, 10.1016\u002FS0002-9378(99)70253-X\nTanaka, 1999, Gasless laparoscopy under epidural anesthesia for adnexal cysts during pregnancy, J. Reprod. Med., 44, 929",{"ES":1626},"Tumores del ovario y embarazo",{"VOID":1628},"10.1016\u002Fs1283-081x(07)70839-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X07708391",[1631,1648,1660],{"id":1632,"sortIndex":36,"researcher":26,"roles":1633,"affiliations":1634,"properties":1645},"36193e39-c5d8-4441-8407-624917a81dd4",[696],[1635],{"id":26,"sortIndex":36,"affiliation":1636,"properties":26},{"id":1637,"createTime":1638,"updateTime":1639,"relativeEntities":1640,"slug":1641,"properties":1642,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"0904b1c9-36ee-4da1-a241-99746b48bd21","2023-12-09T17:52:26.254+00:00","2025-06-11T21:59:09.855+00:00",[],"H%C3%B4pital-Antoine-B%C3%A9cl%C3%A8re-157-rue-de-la-Porte-de-Trivaux-92140-Clamart-France",{"title":1643},{"VI":1644},"Hôpital Antoine Béclère, 157, rue de la Porte-de-Trivaux, 92140 Clamart, France",{"title":1646},{"VI":1647},"A. Chauveaud-Lambling",{"id":1649,"sortIndex":115,"researcher":26,"roles":1650,"affiliations":1651,"properties":1657},"ee469802-0a98-47b5-b862-075f56951c5b",[696],[1652],{"id":26,"sortIndex":36,"affiliation":1653,"properties":26},{"id":1637,"createTime":1638,"updateTime":1639,"relativeEntities":1654,"slug":1641,"properties":1655,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1656},{"VI":1644},{"title":1658},{"VI":1659},"O. Picone",{"id":1661,"sortIndex":114,"researcher":26,"roles":1662,"affiliations":1663,"properties":1669},"2774061d-3c42-4f27-8367-8e848c441df9",[696],[1664],{"id":26,"sortIndex":36,"affiliation":1665,"properties":26},{"id":1637,"createTime":1638,"updateTime":1639,"relativeEntities":1666,"slug":1641,"properties":1667,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1668},{"VI":1644},{"title":1670},{"VI":1671},"H. Fernandez",{"url":1629,"publisher":1673,"properties":1681},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1674,"slug":662,"properties":1675,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1678,"manageAffiliations":1679,"indexDatabases":1680,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1676,"title":1677},{"VOID":665},{"EN":667},[],[],[],{"volume":1682,"pages":1684},{"VOID":1683},"43",{"VOID":943},"2007-01-01",2007,{"id":1688,"createTime":1689,"updateTime":1690,"relativeEntities":1691,"slug":1692,"properties":1693,"entityType":688,"verifyStatus":25,"verifyTime":1690,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1699,"fullTextUrl":26,"authors":1700,"publicationType":747,"publisherRelationship":1750,"citationCount":26,"citationInfo":26,"publishDate":1763,"publishYear":945,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"1db8620f-9778-485b-b4df-b86430b750c5","2024-02-12T15:21:04.685+00:00","2025-02-26T05:04:22.097+00:00",[],"Amenorreas",{"references":1694,"title":1696,"doi":1697},{"VOID":1695},"Pettersson, 1973, Epidemiology of secondary amenorrhea. I. Incidence and prevalence rates, Am J Obstet Gynecol, 117, 80, 10.1016\u002F0002-9378(73)90732-1\nHerman-Giddens, 1997, Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network, Pediatrics, 99, 505, 10.1542\u002Fpeds.99.4.505\nCurrent evaluation of amenorrhea. Fertil Steril 2008;90(Suppl. 5):S219–225.\nLe Trong A, Lopes P. Aménorrhée post pilule. EMC (Elsevier Masson SAS, Paris), Gynécologie, 700-A-40, 2007.\nSeminara, 2003, The GPR54 gene as a regulator of puberty, N Engl J Med, 349, 1614, 10.1056\u002FNEJMoa035322\nBrioude, 2010, Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships, Eur J Endocrinol, 162, 835, 10.1530\u002FEJE-10-0083\nKim, 2010, WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome, Am J Hum Genet, 87, 465, 10.1016\u002Fj.ajhg.2010.08.018\nKim, 2011, The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome, Mol Cell Endocrinol, 346, 74, 10.1016\u002Fj.mce.2011.07.013\nBouligand, 2009, Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation, N Engl J Med, 360, 2742, 10.1056\u002FNEJMoa0900136\nde Roux, 1997, A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor, N Engl J Med, 337, 1597, 10.1056\u002FNEJM199711273372205\nde Roux, 2001, Inherited disorders of GnRH and gonadotropin receptors, Mol Cell Endocrinol, 179, 83, 10.1016\u002FS0303-7207(01)00471-3\nLayman, 2001, Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals, Fertil Steril, 75, 1148, 10.1016\u002FS0015-0282(01)01782-4\nTopaloglu, 2012, Inactivating KISS1 mutation and hypogonadotropic hypogonadism, N Engl J Med, 366, 629, 10.1056\u002FNEJMoa1111184\nde Roux, 2003, Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54, Proc Natl Acad Sci USA, 100, 10972, 10.1073\u002Fpnas.1834399100\nTopaloglu, 2009, TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction, Nat Genet, 41, 354, 10.1038\u002Fng.306\nYoung, 2010, TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans, J Clin Endocrinol Metab, 95, 2287, 10.1210\u002Fjc.2009-2600\nLowry, 1996, Secondary amenorrhea due to hydrocephalus treated with endoscopic ventriculocisternostomy. Case report, J Neurosurg, 85, 1148, 10.3171\u002Fjns.1996.85.6.1148\nAscoli, 2006, Hypopituitarism, Pituitary, 9, 335, 10.1007\u002Fs11102-006-0416-5\nVerrotti, 2009, Epilepsy, sex hormones and antiepileptic drugs in female patients, Expert Rev Neurother, 9, 1803, 10.1586\u002Fern.09.112\nVuong, 2010, The effects of opioids and opioid analogs on animal and human endocrine systems, Endocr Rev, 31, 98, 10.1210\u002Fer.2009-0009\nNutrition and reproduction in women. Hum Reprod Update 2006;12:193–207.\nGenazzani, 2006, Diagnostic and therapeutic approach to hypothalamic amenorrhea, Ann N Y Acad Sci, 1092, 103, 10.1196\u002Fannals.1365.009\nMeczekalski, 2008, Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations, Gynecol Endocrinol, 24, 4, 10.1080\u002F09513590701807381\nFrisch, 1974, Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset, Science, 185, 949, 10.1126\u002Fscience.185.4155.949\nWarren, 2003, Exercise-induced endocrine pathologies, J Endocrinol Invest, 26, 873, 10.1007\u002FBF03345238\nGordon, 2010, Clinical practice. Functional hypothalamic amenorrhea, N Engl J Med, 363, 365, 10.1056\u002FNEJMcp0912024\nPetraglia, 2008, Hormone-dependent gynaecological disorders: a pathophysiological perspective for appropriate treatment, Best Pract Res Clin Obstet Gynaecol, 22, 235, 10.1016\u002Fj.bpobgyn.2007.07.005\nTolle, 2003, Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women, J Clin Endocrinol Metab, 88, 109, 10.1210\u002Fjc.2002-020645\nWelt, 2004, Recombinant human leptin in women with hypothalamic amenorrhea, N Engl J Med, 351, 987, 10.1056\u002FNEJMoa040388\nNavarro, 2009, Regulation of gonadotropin-releasing hormone secretion by kisspeptin\u002Fdynorphin\u002Fneurokinin B neurons in the arcuate nucleus of the mouse, J Neurosci, 29, 11859, 10.1523\u002FJNEUROSCI.1569-09.2009\nKelesidis, 2010, Narrative review: the role of leptin in human physiology: emerging clinical applications, Ann Intern Med, 152, 93, 10.7326\u002F0003-4819-152-2-201001190-00008\nCastellano, 2005, Changes in hypothalamic KISS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition, Endocrinology, 146, 3917, 10.1210\u002Fen.2005-0337\nChan, 2005, Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa, Lancet, 366, 74, 10.1016\u002FS0140-6736(05)66830-4\nCaronia, 2011, A genetic basis for functional hypothalamic amenorrhea, N Engl J Med, 364, 215, 10.1056\u002FNEJMoa0911064\nCortet-Rudelli, 2007, Etiological diagnosis of hyperprolactinemia, Ann Endocrinol, 68, 98, 10.1016\u002Fj.ando.2007.03.013\nTolis, 1997, Amenorrhea in beta-homozygous thalassemia major, Ann N Y Acad Sci, 816, 274, 10.1111\u002Fj.1749-6632.1997.tb52151.x\nMatthews, 1993, Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone, Nat Genet, 5, 83, 10.1038\u002Fng0993-83\nHuhtaniemi, 1999, Mutations and polymorphisms in gonadotropin genes, Mol Cell Endocrinol, 151, 89, 10.1016\u002FS0303-7207(99)00015-5\nLayman, 1997, Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene, N Engl J Med, 337, 607, 10.1056\u002FNEJM199708283370905\nAittomäki, 1995, Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure, Cell, 82, 959, 10.1016\u002F0092-8674(95)90275-9\nLatronico, 2006, Inactivating mutations of LH and FSH receptors--from genotype to phenotype, Pediatr Endocrinol Rev, 4, 28\nArnhold, 1999, Menstrual disorders and infertility caused by inactivating mutations of the luteinizing hormone receptor gene, Fertil Steril, 71, 597, 10.1016\u002FS0015-0282(98)00517-2\nArnhold, 2009, Inactivating mutations of luteinizing hormone beta-subunit or luteinizing hormone receptor cause oligo-amenorrhea and infertility in women, Horm Res, 71, 75, 10.1159\u002F000183895\nNorman, 2007, Polycystic ovary syndrome, Lancet, 370, 685, 10.1016\u002FS0140-6736(07)61345-2\nRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7.\nDewailly, 2011, Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries, Hum Reprod, 26, 3123, 10.1093\u002Fhumrep\u002Fder297\nDewailly, 2010, Which morphological investigations and how to interpret them to make the diagnosis of PCOS?, Ann Endocrinol, 71, 183, 10.1016\u002Fj.ando.2010.02.008\nPigny, 2003, Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest, J Clin Endocrinol Metab, 88, 5957, 10.1210\u002Fjc.2003-030727\nRobin, 2010, Polycystic ovary syndrome: a model of follicular excess, Gynecol Obstet Fertil, 38, 405, 10.1016\u002Fj.gyobfe.2010.04.006\nBry-Gauillard, 2008, Primary amenorrhea revealing an occult progesterone-secreting ovarian tumor, Fertil Steril, 90, 10.1016\u002Fj.fertnstert.2007.11.064\nKurihara, 2004, Inhibin-producing ovarian granulosa cell tumor as a cause of secondary amenorrhea: case report and review of the literature, J Obstet Gynaecol Res, 30, 439, 10.1111\u002Fj.1447-0756.2004.00231.x\nRobin G, Baffet H, Catteau-Jonard S, Dewailly D. Déficits en 21-hydroxylase et fertilité féminine. Med Ther Med Reprod 2012;(sous presse).\nChristin-Maitre, 2008, General mechanisms of premature ovarian failure and clinical check-up, Gynecol Obstet Fertil, 36, 857, 10.1016\u002Fj.gyobfe.2008.07.003\nDe Vos, 2010, Primary ovarian insufficiency, Lancet, 376, 911, 10.1016\u002FS0140-6736(10)60355-8\nAiman, 1985, Premature ovarian failure, Obstet Gynecol, 66, 9\nCoulam, 1986, Incidence of premature ovarian failure, Obstet Gynecol, 67, 604\nSybert, 2004, Turner's syndrome, N Engl J Med, 351, 1227, 10.1056\u002FNEJMra030360\nDavenport, 2010, Approach to the patient with Turner syndrome, J Clin Endocrinol Metab, 95, 1487, 10.1210\u002Fjc.2009-0926\nCarrel, 2005, X-inactivation profile reveals extensive variability in X-linked gene expression in females, Nature, 434, 400, 10.1038\u002Fnature03479\nModi, 2003, Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads, Mol Hum Reprod, 9, 219, 10.1093\u002Fmolehr\u002Fgag031\nLaml, 2002, Genetic disorders in premature ovarian failure, Hum Reprod Update, 8, 483, 10.1093\u002Fhumupd\u002F8.5.483\nPersani, 2009, Primary ovarian insufficiency: X chromosome defects and autoimmunity, J Autoimmun, 33, 35, 10.1016\u002Fj.jaut.2009.03.004\nAllingham-Hawkins, 1999, Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data, Am J Med Genet, 83, 322, 10.1002\u002F(SICI)1096-8628(19990402)83:4\u003C322::AID-AJMG17>3.0.CO;2-B\nConway, 1998, Fragile X premutation screening in women with premature ovarian failure, Hum Reprod, 13, 1184, 10.1093\u002Fhumrep\u002F13.5.1184\nCrisponi, 2001, The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis\u002Fptosis\u002Fepicanthus inversus syndrome, Nat Genet, 27, 159, 10.1038\u002F84781\nBerry, 2008, Galactosemia and amenorrhea in the adolescent, Ann N Y Acad Sci, 1135, 112, 10.1196\u002Fannals.1429.038\nYanase, 1991, 17 alpha-hydroxylase\u002F17,20-lyase deficiency: from clinical investigation to molecular definition, Endocr Rev, 12, 91, 10.1210\u002Fedrv-12-1-91\nKöhler, 2004, An N-terminal WT1 mutation (P181S) in an XY patient with ambiguous genitalia, normal testosterone production, absence of kidney disease and associated heart defect: enlarging the phenotypic spectrum of WT1 defects, Eur J Endocrinol, 150, 825, 10.1530\u002Feje.0.1500825\nAchermann, 2002, Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner, J Clin Endocrinol Metab, 87, 1829, 10.1210\u002Fjcem.87.4.8376\nHarley, 2003, The molecular action and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9], Endocr Rev, 24, 466, 10.1210\u002Fer.2002-0025\nShahid, 2008, Analysis of the SRY gene in two sex-reversed XY sisters identifies two new novel point mutations in the high mobility group box domain, Fertil Steril, 90, 10.1016\u002Fj.fertnstert.2007.11.062\nMolina, 2005, Chemotherapy-induced ovarian failure: manifestations and management, Drug Saf, 28, 401, 10.2165\u002F00002018-200528050-00004\nMertens, 2001, Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study, J Clin Oncol, 19, 3163, 10.1200\u002FJCO.2001.19.13.3163\nChapman, 1982, Effect of cytotoxic therapy on sexuality and gonadal function, Semin Oncol, 9, 84\nLaBarbera, 1988, Autoimmune etiology in premature ovarian failure, Am J Reprod Immunol Microbiol, 16, 115, 10.1111\u002Fj.1600-0897.1988.tb00180.x\nHoek, 1997, Premature ovarian failure and ovarian autoimmunity, Endocr Rev, 18, 107\nLivshits, 2009, Fertility issues in women with diabetes, Womens Health, 5, 701\nMorcel, 2008, The Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: clinical description and genetics, J Gynecol Obstet Biol Reprod, 37, 539, 10.1016\u002Fj.jgyn.2008.07.002\nMorcel, 2011, Utero-vaginal aplasia (Mayer-Rokitansky-Küster-Hauser syndrome) associated with deletions in known DiGeorge or DiGeorge-like loci, Orphanet J Rare Dis, 6, 9, 10.1186\u002F1750-1172-6-9\nSultan, 2009, Mayer-Rokitansky-Kuster-Hauser syndrome: recent clinical and genetic findings, Gynecol Endocrinol, 25, 8, 10.1080\u002F09513590802288291\nBiason-Lauber, 2004, A WNT4 mutation associated with Müllerian-duct regression and virilization in a 46,XX woman, N Engl J Med, 351, 792, 10.1056\u002FNEJMoa040533\nBiason-Lauber, 2007, WNT4 deficiency--a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report, Hum Reprod, 22, 224, 10.1093\u002Fhumrep\u002Fdel360\nPhilibert, 2008, Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and mullerian duct abnormalities: a French collaborative study, J Clin Endocrinol Metab, 93, 895, 10.1210\u002Fjc.2007-2023\nPhilibert, 2011, Molecular analysis of WNT4 gene in four adolescent girls with mullerian duct abnormality and hyperandrogenism (atypical Mayer-Rokitansky-Küster-Hauser syndrome), Fertil Steril, 95, 2683, 10.1016\u002Fj.fertnstert.2011.01.152\nYu, 2008, Asherman syndrome--one century later, Fertil Steril, 89, 759, 10.1016\u002Fj.fertnstert.2008.02.096\nMyers, 2012, Comprehensive management of severe Asherman syndrome and amenorrhea, Fertil Steril, 97, 160, 10.1016\u002Fj.fertnstert.2011.10.036",{"ES":1692},{"VOID":1698},"10.1016\u002Fs1283-081x(15)70992-6","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X15709926",[1701,1715,1727,1738],{"id":1702,"sortIndex":115,"researcher":26,"roles":1703,"affiliations":1704,"properties":1713},"f40bb5e3-e911-480e-a220-030998af9f93",[696],[1705],{"id":26,"sortIndex":36,"affiliation":1706,"properties":26},{"id":1707,"createTime":1708,"updateTime":1708,"relativeEntities":1709,"slug":26,"properties":1710,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a7ee8b04-5217-470c-ae4c-61e84cf3a7d4","2024-02-12T15:21:04.771+00:00",[],{"title":1711},{"VI":1712},"Service de gynécologie endocrinienne et de médecine de la reproduction, département de gynécologie, Hôpital Jeanne-de-Flandre, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":1714},{"VI":1238},{"id":1716,"sortIndex":114,"researcher":26,"roles":1717,"affiliations":1718,"properties":1724},"871da508-bfb7-4962-8a7b-7445d5208684",[696],[1719],{"id":26,"sortIndex":36,"affiliation":1720,"properties":26},{"id":1707,"createTime":1708,"updateTime":1708,"relativeEntities":1721,"slug":26,"properties":1722,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1723},{"VI":1712},{"title":1725},{"VI":1726},"S. Catteau-Jonard",{"id":1728,"sortIndex":59,"researcher":26,"roles":1729,"affiliations":1730,"properties":1736},"683dba9d-8471-459d-adc8-5967d52a3f19",[696],[1731],{"id":26,"sortIndex":36,"affiliation":1732,"properties":26},{"id":1707,"createTime":1708,"updateTime":1708,"relativeEntities":1733,"slug":26,"properties":1734,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1735},{"VI":1712},{"title":1737},{"VI":973},{"id":1739,"sortIndex":36,"researcher":26,"roles":1740,"affiliations":1741,"properties":1747},"d91b8b5a-c917-4af3-b4f9-011ecce4e8ee",[696],[1742],{"id":26,"sortIndex":36,"affiliation":1743,"properties":26},{"id":1707,"createTime":1708,"updateTime":1708,"relativeEntities":1744,"slug":26,"properties":1745,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1746},{"VI":1712},{"title":1748},{"VI":1749},"M. Peigné",{"url":1699,"publisher":1751,"properties":1759},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1752,"slug":662,"properties":1753,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1756,"manageAffiliations":1757,"indexDatabases":1758,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1754,"title":1755},{"VOID":665},{"EN":667},[],[],[],{"volume":1760,"pages":1761},{"VOID":941},{"VOID":1762},"1-17","2015-06-01"]